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ABSTRACT  
 
  Smoking remains the leading cause of preventable death in the United States, and 
early initiation is associated with greater difficulty quitting.  Among adolescent smokers, 
those with attention-deficit hyperactivity disorder (ADHD), characterized by difficulties 
associated with impulsivity, hyperactivity, and inattention, smoke at nearly twice the rate 
of their peers.  Although cigarette smoking is highly addictive, nicotine is a relatively 
weak primary reinforcer, spurring research on other potential targets that may maintain 
smoking, including the potential benefits of nicotine on attention, inhibition, and 
reinforcer efficacy.  The present study employs the most prevalent rodent model of 
ADHD, the spontaneously hypertensive rat (SHR) and its control comparison Wistar 
Kyoto (WKY) to examine the effects of acute and chronic subcutaneous nicotine 
injections on performance in three operant response inhibition paradigms.  Functional 
activation in select regions of the prefrontal cortex and striatum was also explored.  Acute 
(0.1, 0.3, 0.6 mg/kg) and chronic (0.3 mg/kg) nicotine increased impulsive responding 
regardless of strain, dose, or operant schedule.  Dose-dependent decreases in latency to 
initiate the task were also observed.  SHR receiving daily nicotine injections showed less 
activation in the nucleus accumbens shell compared to saline controls.  Despite close 
similarities, one of the three operant tasks did not detect response inhibition deficits in 
SHR relative to WKY.  A closer examination of these tasks may highlight critical 
components involved in the amelioration of response inhibition deficits.   
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CHAPTER 1 
GENERAL INTRODUCTION 
Response inhibition is broadly defined as the ability to withhold a response 
(Bardo, Cain, & Bylica, 2006).  Response inhibition deficits are a central feature of 
several psychiatric disorders, including attention-deficit hyperactivity disorder (ADHD), 
bipolar disorder, and substance use disorders (Grant, Levine, Kim, & Potenza, 2005). 
Accurate assessment of these deficits is critical to accomplishing three goals: (A) 
identifying people in need of treatment, (B) identifying environmental arrangements or 
drugs that alleviate the deficits, and (C) uncovering the neural underpinnings of the 
behavioral deficit. 
Although disorders of inhibitory control are typically diagnosed using clinical 
interviews and behavior rating scales (Costello, Edelbrock, Kalas, Kessler, & Klaric, 
1982; Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000), laboratory measures offer 
several advantages.  Laboratory tasks can be administered relatively quickly compared to 
clinical diagnoses, thereby reducing costs and allowing for more participants or more 
frequent observations.  Increased ease of administration also facilitates data collection at 
multiple time points, or in conjunction with the manipulation of variables, e.g., 
reinforcement contingencies, drugs, or distractors.  Laboratory tasks rely on quantitative 
dependent measures that are more amenable to replication than qualitative ones, 
increasing overall consistency.  Lastly, laboratory tasks used on human subjects often 
translate well to experiments with non-human animals, whereas clinical reports such as 
interviews or parent/teacher ratings offer no animal analogue (Nichols & Waschbusch, 
2004). 
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Behavioral tasks designed to assess response inhibition typically require subjects 
to withhold a previously reinforced response.  Beyond that similarity, however, response 
inhibition tasks vary widely in their design and implementation, and the inferences that 
can be drawn from their dependent measures.  We begin by discussing several standard 
response inhibition tasks used with humans and animals.  After evaluating the 
contribution of each task to the three aforementioned goals, we offer a potential 
alternative task, and introduce a quantitative model to further enhance the resolution of 
response inhibition data. 
 
Go/no-go and stop signal task 
Response inhibition is often assessed in humans using variations of the go/no-go 
task (Newman, Widom, & Nathan, 1985; Wodka et al., 2007), or the stop signal task 
(SST; Aron, Fletcher, Bullmore, Sahakian, & Robbins, 2003; Logan, Schachar, & 
Tannock, 1997).  Both tasks are designed to measure ‘action inhibition,’ or the ability to 
inhibit a pre-planned physical response (Eagle, Bari, & Robbins, 2008).  Participants are 
required to perform hurried responses on “go” trials and withhold responses on ‘no-go’ or 
‘stop’ trials (Aron, Fletcher, et al., 2003).  In go/no-go tasks, subjects must respond 
quickly to a “go” stimulus on the majority of trials, and withhold responding in the 
presence of a “stop” stimulus on other trials.  Estimates of action inhibition from go/no-
go performance are calculated from the proportion of errors of commission, i.e., the 
proportion of incorrect responses during “stop” trials.  In the SST, a “go” stimulus is 
presented on every trial; on select trials a “stop” signal is presented shortly after the “go” 
signal, thus participants must inhibit responding after they have already been presented 
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with a “go” stimulus.  The dependent measure, the stop-signal reaction time, is an 
estimate of the minimum time needed to execute the stop response, which is derived from 
Logan and Cowan’s (1984) race model.   
The SST estimates the speed at which an ongoing response is inhibited, whereas 
the go/no-go task is an estimate of the ability to inhibit the initiation of a response.  
Although the distinction may seem slight, the go/no-go task involves response choice 
selection in addition to inhibition, whereas the SST only requires the cancellation of a 
response that has already been selected (Dalley, Everitt, & Robbins, 2011; Eagle et al., 
2008; Eagle & Baunez, 2010).  As a result, the SST is regarded as more dynamic and 
“cognitively pure” than the go/no-go task (Aron & Poldrack, 2005).   
Discriminant validity, or the ability to accurately discriminate psychiatric 
populations from normal controls, is an important feature of a response inhibition task.  A 
meta-analysis of seven studies reported that SST accurately distinguishes children with 
ADHD from normal controls (Oosterlaan, Logan, & Sergeant, 1998).  Poor performance 
on the SST has been correlated with off task and hyperactive behavior in classroom 
situations (r = .65), and with teacher ratings of inattention and hyperactivity (r = .37) 
(Pliszka, Borcherding, Spratley, Leon, & Irick, 1997).  Similarly, results from go/no-go 
tasks show that children with ADHD produce more errors than controls (Van der Meere, 
Marzocchi, & De Meo, 2005; Wodka et al., 2007). 
SST performance is also sensitive to pharmacological effects.  Stop signal 
performance improves under the administration of various stimulants, including those 
used to treat ADHD (Aron, Dowson, Sahakian, & Robbins, 2003; Boonstra, Kooij, 
Oosterlaan, Sergeant, & Buitelaar, 2005; de Wit, Enggasser, & Richards, 2002; Eagle et 
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al., 2008), as well as modafinil (R. E. Morgan, Crowley, Smith, LaRoche, & Dopheide, 
2007).  Interestingly, these drugs improve the stop signal reaction time without affecting 
the “go” reaction time, or the time required to initiate a response.  This suggests that these 
stimulants (MPH, d-amphetamine, modafinil) are affecting processes related to 
inhibition, not simply improving overall reaction time.  Alternatively, cocaine increases 
stop signal reaction time (Fillmore, Rush, & Hays, 2002), supporting existing evidence 
that cocaine is detrimental to response inhibition in humans (C. R. Li, Milivojevic, Kemp, 
Hong, & Sinha, 2006; Moeller et al., 2002) and non-human primates (Jentsch & Taylor, 
1999; Liu, Heitz, & Bradberry, 2009). 
Animal analogues to the go/no-go task and SST have been used in lesion studies 
and with knockout mice, to explore the neurobiology underlying response inhibition (for 
review, see Eagle, Bari, & Robbins, 2008).  Go/no-go tasks have also provided evidence 
that a variety of drugs are detrimental to action inhibition, including nicotine in rodents 
(Kolokotroni, Rodgers, & Harrison, 2011), selective α-2 antagonists in primates (Arnsten 
& Li, 2004), and alcohol and ketamine in humans (Finn, Justus, Mazas, & Steinmetz, 
1999; C. J. Morgan, Mofeez, Brandner, Bromley, & Curran, 2004). 
The SST and go/no-go tasks are generally regarded as useful tools for studying 
response inhibition, but they are not without their limitations.  An inability to withhold 
responding in either task might be interpreted as deficient motor processing, not 
inhibition (Van der Meere et al., 2005).  To account for this possibility, the “go” reaction 
time is used to measure the relative duration required to execute the response, 
independent of inhibitory processing.  Manipulations that affect inhibitory performance, 
but not “go” reaction time are presumed to operate on inhibitory processes, whereas 
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manipulations that affect both become difficult to interpret. This limits the utility of these 
tasks for studying the effects of drugs that directly affect reaction time, such as alcohol.  
The SST utilizes visual go signals, but auditory stop signals, drawing criticism because 
children with ADHD may be particularly poor at auditory processing (Nigg, 2000; Van 
der Meere et al., 2005).    
 
Differential reinforcement of low rates schedule 
Another method for assessing response inhibition is the differential reinforcement 
of low rates (DRL) schedule (Skinner, 1938). DRL requires subjects to wait a specified 
interval between consecutive responses; only responses made after the interval elapses 
are considered ‘correct,’ and are reinforced. Responses are often made on a mechanical 
lever or button, but DRL schedules can be administered manually as well.  Their simple 
design and implementation makes them highly attractive to laboratory researchers.  
Unlike the SST and go/no-go tasks, which require the inhibition of responses to discrete 
stimuli, DRL is considered a measure of ‘waiting impulsivity,’ (Eagle et al., 2008; 
Robinson et al., 2009) because subjects must inhibit responding for a specific period of 
time, i.e., successfully ‘wait’ in between responses.  Performance can be summarized by 
the proportion of correct responses, or by the mean waiting interval (i.e., mean duration 
between consecutive responses).  
Although DRL schedules originated from early operant animal work and remain 
more prevalent there, they have been shown to discriminate between children with and 
without ADHD (Gordon, 1979; McClure & Gordon, 1984; Solanto, 1990) and children 
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with conduct disorder (Shapiro, Quay, Hogan, & Schwartz, 1988), while others have 
found no differences (Daugherty & Quay, 1991).   
Despite a relatively small body of supporting clinical literature, DRL is still 
widely used in animal research as a response inhibition task. DRL schedules have been 
used with animals to examine the effects of a variety of drugs on response inhibition, 
including nicotine (Kirshenbaum et al., 2011; Kirshenbaum, Brown, Hughes, & Doughty, 
2008; Kirshenbaum, Johnson, Schwarz, & Jackson, 2009; C. Morrison & Armitage, 
1967; C. F. Morrison, 1968; Popke, Fogle, & Paule, 2000; Popke, Mayorga, Fogle, & 
Paule, 2000), caffeine (Webb & Levine, 1978), and cocaine (Wenger & Wright, 1990; 
Woolverton, Kandel, & Schuster, 1978).  In general, these stimulants reduce the time 
between consecutive responses in humans and non-human animals, suggesting that 
stimulants increase impulsive responding.  However, stimulant medications used to treat 
ADHD, such as MPH or d-amphetamine, also appear to impair DRL responding 
(Emmett-Oglesby, Taylor, & Dafter, 1980; Ferguson et al., 2007; Seiden, Andresen, & 
MacPhail, 1979) or have no effect (Andrzejewski et al., 2014). These results are 
inconsistent with evidence from human literature suggesting that ADHD medications 
improve inhibitory control.  
The failure of DRL schedules to corroborate human literature on the beneficial 
effects of ADHD medications on inhibitory control highlights a serious limitation of the 
task.  One potential explanation is that DRL performance relies on time estimation, which 
may be altered by stimulants.  If stimulant drugs cause time to be overestimated (i.e., 
time seems to pass more quickly), this could increase premature responding under DRL 
schedules.  
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Alternatively, the sensitivity of DRL to changes in motivation may underlie 
deficient performance under MPH and d-AMPH.  In DRL schedules, the ability to 
withhold a response is confounded with reinforcer efficacy (Doughty & Richards, 2002; 
Hill, Covarrubias, Terry, & Sanabria, 2012).  Hence DRL performance worsens as the 
quality of the reinforcer or deprivation level increases; under circumstances where the 
reinforcer is devalued, animals tend to respond less frequently.  In DRL schedules, where 
reinforcement is contingent on waiting, infrequent responding may actually improve the 
proportion of correct responses, and increase the duration of the mean waiting interval.  If 
MPH or d-AMPH increase the reinforcing efficacy of food reward, the result could be 
deficient DRL performance, regardless of the drugs’ effects on inhibitory control. 
 
A potential alternative: the Fixed Minimum Interval (FMI) schedule 
The Fixed Minimum Interval (FMI) schedule of reinforcement (Mechner & 
Guevrekian, 1962), like the DRL schedule, is a form of ‘waiting’ task that purports to 
measure response inhibition (Hill et al., 2012).  It is implemented similarly to DRL 
schedules, but in FMI schedules the response that initiates the waiting interval differs 
from the response that terminates it.  
In FMI schedules, reinforcement is contingent upon successfully withholding a 
target response for a programmed time interval. Intervals are initiated with a lever press 
and terminated with a head entry into the food hopper (the target response). Head entries 
made after the programmed interval elapses are reinforced. Although this arrangement is 
similar to the DRL schedule, a key difference is that in FMI schedules the topography 
and location of the initial response (lever press) differs from the terminal response (head 
   8
entry). In this way, FMI schedules dissociate the capacity to withhold the target response 
(inferred from the intervals between initial and terminal responses) from the efficacy of 
the reinforcer in maintaining initial responses (inferred from the intervals between trial 
onset and initial response) (Hill et al., 2012; Mechner & Guevrekian, 1962).  
FMI schedules have been used rather sparingly in comparison to DRL. More 
recently, however, our laboratory has evaluated FMI schedules as an alternative to DRL.  
Using FMI schedules we have shown that the mean waiting interval, an index of 
inhibitory performance, decreases under chronic stress (Mika et al., 2012), and increases 
under acute MPH (Hill et al., 2012).  The latter finding is particularly important when 
considering the effects of MPH on DRL performance.  If FMI schedules are sensitive to 
ameliorative effects of MPH, they may offer added utility over DRL schedules in the 
evaluation of drugs that alleviate response inhibition deficits. 
The purpose of Chapters 2 and 3 was to evaluate FMI performance in response to 
acute (Ch. 2) and chronic (Ch. 3) nicotine, a drug with potentially therapeutic effects on 
ADHD symptoms (see Ch. 2 introduction for details).  Chapter 4 aims at identifying 
causes for the differences in performance observed between FMI and DRL schedules.  
 
The temporal regulation model 
In each experiment presented here, the temporal regulation (TR) model (Hill et 
al., 2012; Mika et al., 2012; Sanabria & Killeen, 2008) was applied to estimate 
parameters of the distribution of waiting intervals (see Appendix for detailed model 
description).  The distribution of waiting intervals produced in response-withholding 
tasks is often contaminated with short “burst” waiting intervals that do not appear to be 
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sensitive to the criterial waiting requirement, but instead occur at random and follow an 
exponential distribution (Sanabria & Killeen, 2008).  The TR model uses a mixture of 
two distributions—one exponential, and one gamma—to model the distribution of 
waiting intervals, and allows for the analysis of response withholding performance 
independently of “burst” responses (Sanabria & Killeen, 2008).  The TR model assumes 
that waiting intervals can be categorized as ‘timed’ (i.e., the subject is engaged in the 
timing task), or ‘non-timed’ (i.e., the subject is not engaged in the task).  ‘Timed’ waiting 
intervals are characterized by a gamma distribution, and ‘non-timed’ responses, such as 
rapid burst responses or extended intervals of chamber exploration, are characterized by 
an exponential distribution. 
 There are two estimates derived from the TR model that serve as dependent 
variables throughout each experiment.  Response inhibition performance is indexed by θ, 
the mean timed waiting interval  (i.e., ‘non-timed’ intervals are excluded).  The parameter 
P represents the proportion of ‘timed’ responses. 
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CHAPTER 2 
DETRIMENTAL EFFECTS OF ACUTE NICOTINE ON THE RESPONSE-
WITHHOLDING PERFORMANCE OF SPONANEOUSLY HYPERTENSIVE AND 
WISTAR KYOTO RATS 
 
Attention-deficit hyperactivity disorder (ADHD) is among the most common 
childhood psychiatric disorders, affecting between 2% and 10% of children worldwide 
(Froehlich et al. 2007; Skounti et al. 2007), with symptoms often persisting into 
adulthood (Kessler et al. 2006). Barkley (1997) suggested that the core features of ADHD 
are deficits in response inhibition capacity and sustained attention. Response inhibition 
capacity refers to the ability to withhold a reinforced response; it is typically assessed in 
humans using Go/No-Go tasks (e.g., Wodka et al. 2007). Sustained attention refers to the 
effortful maintenance of responding to a stimulus; it is typically assessed using vigilance 
tasks (e.g., Stins et al. 2005). 
ADHD is associated with early initiation of tobacco smoking, and with habitual 
smoking during adolescence (Lambert and Hartsough 1998; Milberger et al. 1997). The 
higher prevalence of smoking among individuals with ADHD may be due to tobacco 
smoking ameliorating some ADHD-related deficits (Blume et al. 2000; Gehricke et al. 
2007; Khantzian 1997; Pomerleau et al. 2000). Because nicotine is the main psychoactive 
ingredient of tobacco, it is possible that nicotine enhances response inhibition and/or 
sustained attention. 
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Effects of nicotine on response inhibition capacity 
The effects of nicotine on response inhibition capacity in humans are somewhat 
disparate. Although acute nicotine has been shown to enhance the capacity to withhold an 
ongoing response in the STT regardless of smoking or ADHD status (Potter et al. 2012; 
Potter and Newhouse 2008; Potter and Newhouse 2004), these findings are inconsistent 
with other data from the SST (Wignall & de Wit, 2011) and the continuous performance 
task (Bekker, Böcker, Van Hunsel, van den Berg, & Kenemans, 2005). The effects of 
acute nicotine on estimates of response inhibition capacity obtained from errors of 
commission in vigilance tasks are also inconsistent: whereas some studies report 
substantial nicotine-induced enhancement in vigilance-related response inhibition 
capacity (Myers et al. 2013; Myers et al. 2008), other studies report very mild effects 
(Levin et al. 1998), effects related only to irrelevant stimuli (Dawkins et al. 2007), and 
dose-dependent effects (Bekker et al. 2005). Inconsistent effects of acute nicotine have 
also been observed in biased visual discrimination tasks (Barr et al. 2008; Wignall and de 
Wit 2011) that are discriminative of ADHD status (Tripp and Alsop 1999).  
Unlike humans, acute nicotine administration in rodents consistently increases 
impulsive responding in a wide range of tasks, including the five-choice serial reaction 
time task (5-CSRTT; Bizarro et al. 2004; Blondel et al. 2000; Hahn et al. 2002; 
Semenova et al. 2007), the differential reinforcement of low rates (DRL) schedule of 
reinforcement (Kirshenbaum & Brown, 2008; Kirshenbaum et al., 2011, 2009; Mayorga, 
Popke, Fogle, & Paule, 2000; Popke, Fogle, et al., 2000), the stop-signal task 
(Kirshenbaum et al. 2011), and the go/no-go discrimination (Kolokotroni et al. 2011). 
Only the temporal response differentiation task, which involves holding down a lever for 
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a target interval, appears to be insensitive to nicotine-induced premature responding 
(Popke et al. 2000b). 
 
Effects of nicotine on sustained attention 
Acute nicotine appears to reliably enhance sustained attention in individuals with 
and without ADHD (Conners et al. 1996; Gehricke et al. 2006; Levin et al. 1998; Levin 
et al. 2000, 2001; Warburton 1992; for review see Heishman et al. 2010). Measures 
obtained from rats in the 5-CSRTT suggest that acute nicotine improves sustained 
attention in outbred rodent models as well (Bizarro et al. 2004; Blondel et al. 2000; Day 
et al. 2007; Hahn et al. 2002; Mirza and Stolerman 1998; Semenova et al. 2007). Results 
from a visual signal detection task, another test of vigilance, also support the notion that 
nicotine improves attention in rodents (Rezvani et al. 2002; Rezvani and Levin 2004).   
Human and animal studies are consistent in supporting the ameliorating effects of 
nicotine on sustained attention, but not on response inhibition capacity. In this study, we 
consider an explanation to the latter negative findings. Nicotine may not appear to 
enhance response inhibition capacity in past studies due to (a) the animal models used, 
and/or (b) the method by which response inhibition capacity was assessed in these 
models. 
 
An animal model of ADHD 
The negative effects of nicotine on response inhibition capacity may be due to the 
choice of animal model in which these effects were tested. Subjects in these studies 
typically are outbred rats that may not have inhibitory deficits to rescue. The effect of 
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nicotine on response inhibition capacity may be different in animals that model ADHD-
related inhibitory deficits. The spontaneously hypertensive rat (SHR) is the most widely 
studied animal model of ADHD (Sagvolden 2000; Sagvolden et al. 2009). Despite the 
prevalent use of this strain, the majority of evidence suggests that sustained attention is 
not compromised in SHR (Van den Bergh et al. 2006; Thanos et al. 2010; but see 
Sagvolden and Xu 2008). In contrast, performance in response-withholding paradigms, 
such as the DRL schedule, consistently shows a reduced response inhibition capacity in 
SHR compared to its normoactive control, the Wistar Kyoto rat (WKY; Evenden and 
Meyerson 1999, Ferguson et al. 2007, Orduña et al. 2009; Sagvolden and Berger 1996, 
Sanabria and Killeen 2008; van den Bergh et al. 2006). Therefore, despite its limitations 
as an animal model of ADHD, SHR appears to be an ideal model to test whether or not 
nicotine enhances response inhibition capacity.  
 
Assessing response inhibition capacity 
In DRL schedules, the ability to withhold a response for an incentive is confounded 
with the reinforcing efficacy of the incentive (Doughty and Richards 2002; Hill et al. 
2012). Nicotine may appear to reduce response inhibition capacity when in reality it is 
enhancing the efficacy of a reinforcer. The present study implements a novel response 
inhibition paradigm, the fixed minimum interval (FMI) schedule of reinforcement (see 
general introduction for review), that empirically isolates response inhibition capacity 
from reinforcer efficacy (Hill et al. 2012).  Such dissociation is not possible with DRL 
schedules, because initial and terminal responses are identical. Put simply, levels of 
motivation significantly affect presumed measures of response inhibition capacity in the 
   14 
DRL, but not in the FMI. This difference between FMI and DRL may explain why 
methylphenidate (MPH), which enhances response inhibition capacity in individuals with 
ADHD (Aron et al. 2003; Boonstra et al. 2005; DeVito et al. 2009), also enhances 
response-withholding performance of rats in the FMI (Hill et al. 2012), but not in the 
DRL (Van den Bergh et al. 2006; Ferguson et al. 2007; Hill et al. 2012; Orduña et al. 
2009). In FMI schedules, acute MPH selectively reduces the interval between trial onset 
and initial response (Hill et al., 2012); because this interval and the interval between 
initial and terminal response are confounded in DRL schedules, MPH often induces short 
intervals between consecutive responses (Emmett-Oglesby et al. 1980; Ferguson et al. 
2007; Orduña et al. 2009; Pearl and Seiden 1976; Seiden et al. 1979; but see Hill et al. 
2012). We hypothesize that a similar confound explains nicotine-induced response-
withholding deficits inferred from DRL performance. Thus, it was expected that the FMI 
schedule would reveal a lower baseline response inhibition capacity in SHR relative to 
WKY. Also, in agreement with the symptom amelioration hypothesis of ADHD-related 
smoking, it was expected that the FMI would reveal a nicotine-induced enhancement of 
reinforcer efficacy and inhibitory capacity.  
 
Methods 
Subjects 
 Twenty-three male rats, 12 Spontaneously Hypertensive Rats (SHR/NCrl) and 11 
Wistar Kyoto (WKY/NHsd), arrived on post-natal day (PND) 25 and were pair-housed 
according to strain. Initially, 10 rats of each strain were received, but 3 WKY died within 
3 days of arrival. One rat, left without a cagemate, was added to another pair to make one 
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cage of 3 WKY. Before examining any performance data, a second cohort (4 WKY, 2 
SHR) was added to compensate for the attrition. Both cohorts experienced identical 
procedures throughout the experiment. Shortly upon arrival, the duration of access to 
food was reduced daily from 24 h to 18 h, 12 h, and finally 1 h. For both SHR and WKY, 
this feeding regimen yielded weights at the beginning of each session that were, on 
average, 75.5% of mean ad libitum weights estimated from growth charts provided by the 
breeders. The average difference in weight between cagemates under food restriction was 
approximately 9% of their estimated mean ad libitum weights, which was similar to the 
10% difference observed when food was freely available. Water was available in the 
home cages ad libitum throughout the duration of the experiment. 
 
Apparatus 
Experiments were conducted in 10 MED Associates (St. Albans, VT) modular 
test chambers (three chambers were 305 mm long, 241 mm wide, and 210 mm high; 
seven chambers were 305 mm long, 241 mm wide, and 292 mm high), each enclosed in a 
sound- and light-attenuating box equipped with a ventilating fan. The front and back 
walls and the ceiling of the test chambers were made of Plexiglas; the front wall was 
hinged and served as a door to the chamber. One of the two aluminum side panels served 
as a test panel. The floor consisted of thin metal bars positioned above a catch pan. A 
square opening (51 mm sides) located 15 mm above the floor and centered on the test 
panel provided access to the hopper (MED Associates, ENV-200-R2M) and was 
furnished with a head entry detector (ENV-254-CB). Each activation of a dispenser 
delivered a single 45-mg sucrose pellet (TestDiet, Richmond, IN) to the hopper. A 
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multiple tone generator (MED Associates, ENV-223) was used to produce 3 kHz tones at 
approximately 75 dB through a speaker (MED Associates, ENV-224AM) centered on the 
top of the wall opposite to the test panel, 240 mm above the floor of the chamber. Two 
retractable levers (ENV-112CM) flanked the food hopper, and three-color light stimuli 
(ENV-222M) were mounted above each lever and could be illuminated yellow, green, 
and red. Lever presses were recorded when a force of approximately 0.2 N was applied to 
the end of the lever. The ventilation fan mounted on the rear wall of the sound-
attenuating chamber provided masked noise of approximately 60 dB. The test chambers 
could be dimly illuminated by a houselight located behind the wall opposite to the test 
panel. Experimental events were arranged via a Med-PC® interface connected to a PC 
controlled by Med-PC IV® software. 
 
Procedure 
Figure 1 describes the sequence of events. Sessions were conducted once daily, 7 
days a week. Training initiated with autoshaping, consisting of pairing lever insertion 
with the delivery of a sucrose pellet. Once all rats were responding reliably to the lever, 
FMI training began. During FMI sessions, reinforcement was contingent upon the rat 
successfully waiting a given interval of time. The waiting interval was initiated by a lever 
press and terminated with a head entry into the food hopper. All terminal responses 
resulted in the retraction of the lever and a 5.5-s blackout period, after which the lever 
was reinserted and the next trial began. Each session ended after 60 min or after 150 
sucrose pellets were delivered, whichever happened first. For a detailed description of 
training and the arrangement of sessions, see Mika et al. (2012). 
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At the onset of FMI training, the criterial waiting time (t) was set to 0.5 s. Each 
correct response increased t by 1.25%; t was carried over from one session to the next 
until t = 6 s, and remained constant thereafter. Once the 6-s criterion had been 
established, a conjunctive variable interval (VI) 9-s schedule was introduced and 
gradually increased across sessions, to a VI 30-s schedule. The conjunctive VI 30-s 
schedule was implemented to reduce the between-subject variability in rate of 
reinforcement that would otherwise result from unequal performance (for details, see 
footnote 1). When there were no noticeable upward or downward trends in the proportion 
of correct responses in four consecutive days, as determined by visual inspection of the 
data, the treatment phase began.  
 
Figure 1.  Timeline of events. Rats arrived at the facility on PND 25; after an acclimation 
period, they began lever training on PND 30. FMI training started on PND 40, and once 
performance stabilized on the FMI 6-s schedule, the treatment phase began on PND 57. 
During treatment, rats were injected with saline, three different doses of nicotine (0.1, 
0.3, 0.6 mg/kg), and pre-fed in counterbalanced order. Rats were subjected to each 
treatment cycle twice, with the second cycle beginning on PND 74. On PND 92, the 
criterial waiting time for the FMI schedule was reduced from 6 s to 0.5 s. After 14 days 
of experience with FMI 0.5-s, all animals received 0.6 mg/kg nicotine immediately prior 
to session (PND 106). 
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Nicotine and pre-feeding treatments 
 Prior to PND 52, when treatment commenced, all rats were drug naïve. Treatment 
consisted of either a subcutaneous (s.c.) injection of saline, 0.1, 0.3, or 0.6 mg/kg of 
nicotine, 10 min prior to session, or ad libitum access to food in the home cage during the 
hour leading up to session start. Treatment was implemented twice per week, with at least 
two rest days between treatments. This drug regimen was chosen because neither 
tolerance nor sensitization effects were evidenced in a similar regimen implemented by 
Kirshenbaum et al. (2008) using DRL 4.5-s and Sprague Dawley rats. Within this range 
of doses, acute s.c. nicotine disrupts DRL performance (Kirshenbaum et al., 2008), 
timing (Hinton and Meck, 1996), improves performance in 5-CSRTT (Bizarro and 
Stolerman 2003; Hahn et al. 2003), induces place preference, and enhances social 
rewards (Thiel et al. 2009). 
FMI 6-s sessions were conducted daily. (-)Nicotine hydrogen tartrate (Sigma-
Aldrich, St. Louis, MO) was dissolved in saline, and sodium hydroxide was added until 
the pH of the solution was approximately 7.2. Nicotine dose was calculated as the base, 
and injection volume was based on body weight at the time of injection. All animals 
experienced two determinations of each dose and two pre-feeding (PF) sessions. Each 
animal received each treatment (dose or PF) once (cycle 1) and then again in the same 
order (cycle 2). Treatment order within each cycle was counterbalanced across animals. 
 
FMI with minimal delay 
 Once the two cycles of treatment were completed, two daily FMI 6-s sessions 
were conducted in the absence of nicotine. Immediately following, 15 daily sessions were 
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conducted in which the criterial time was reduced to 0.5 s (FMI 0.5-s). No injections 
were administered until the 15th day, when all rats received 0.6 mg/kg nicotine 
immediately prior to the FMI session. The purpose of this condition was to determine 
whether selected effects of nicotine on FMI 6-s performance were dependent on the 6-s 
waiting period. 
 
Dependent measures  
The primary dependent measures were median latency to initial lever press, and 
selected parameters of the distribution of inter-response times (IRTs), computed for each 
rat over individual sessions. Latencies are the intervals between lever presentation (start 
of the trial) and initial lever press. Latencies were classified into two categories based on 
the outcome of the previous trial:  (1) post-R latencies: those following correct reinforced 
trials, and (2) post-N latencies: those following non-reinforced trials, including those 
following trials in which a correct response went unreinforced because the conjunctive VI 
had not elapsed, as well as those following incorrect responses (i.e., IRT < t). 
IRT refers to the time elapsed between the initial lever press and the terminal head 
entry. The Temporal Regulation model was applied to estimate parameters of the 
distribution of IRTs (Mika et al. 2012; Sanabria and Killeen 2008). The model assumes 
that, at the beginning of every trial, rats sometimes enter a timing state with probability P. 
When in a timing state, rats produce IRTs that are gamma-distributed, centered close to 
the criterial FMI interval (here, 6 s). When rats are not in a timing state, they produce 
IRTs at a constant average rate, and as such, non-timing IRTs are exponentially 
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distributed. Thus, according to the Temporal Regulation model, a mixture of two 
distributions, one gamma and one exponential, underlie the distribution of IRTs:  
 Pr (IRT = t | t < δ) = 0  
 Pr (IRT = t | t ≥ δ) = PΓ (t – δ; n, c) + (1 – P)(1 / K) exp (– (t – δ) / K).  (1) 
In Equation 1, the probability of entering a timing state, P, is the mixture weight of a 
gamma distribution with shape parameter n and scale parameter c. Both distributions, 
gamma and exponential, are shifted rightwards to account for the minimum time required 
to complete an IRT, δ. Thus, the mean duration of timed IRTs is nc + δ and the mean 
duration of non-timed IRTs is K + δ. Our analysis was primarily concerned with 
estimates of P and of the rescaled mean of the gamma distribution, θ = (nc + δ) / 6 s. If 
the mean timed IRT is shorter or longer than the 6-s criterial time, estimates of θ are, 
respectively, less than or greater than 1. Estimates of θ served as indices of response 
inhibition capacity (Sanabria and Killeen, 2008).  
 
Data Analysis 
IRTs and latencies were collected on every treatment day, on the day preceding 
each treatment (no-treatment days), and on the last 2 experimental days (FMI 0.5-s on 
no-treatment and on 0.6 mg/kg nicotine). Median latencies and estimates of θ were log-
transformed. The proportion of correct IRTs (i.e., IRT > 6 s), the proportion of correct 
IRTs reinforced (i.e., reinforced IRTs / total IRTs), and estimates of P were log-odds 
transformed. These transformations follow suggestions on the estimation of population 
parameters in a similar model by Cheung, Neisewander and Sanabria (2012). All 
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dependent measures are reported as back-transformed mean ± SEM. P and θ were 
estimated for each rat using the method of maximum likelihood (Myung 2003).  
 
Analysis of variance (ANOVA). ANOVA was implemented to establish the statistical 
significance of the effects of strain (SHR vs. WKY) and nicotine dose (vehicle vs. 0.1 vs. 
0.3 vs. 0.6 mg/kg) on proportions of correct IRTs and correct IRTs reinforced. The 
effects of strain, nicotine dose, pre-feeding, schedule (FMI 6-s vs. 0.5-s) and treatment 
cycle (first vs. second) were examined on rate of reinforcement, median latencies and 
estimates of P and θ, using a significance threshold of α = .05. When sphericity was 
violated according to Mauchly’s test, a Huynh-Feldt correction was implemented. Only 
significant main effects or interaction effects were followed by post hoc 2-tailed t-tests. 
Significant cycle effects were followed by a separate ANOVA in each cycle. Only 
significant effects are reported. 
Nicotine effects. Separate 2 × 2 × 4 (strain × cycle × dose) mixed-design 
ANOVAs were conducted on median latencies and estimates of P and θ to establish the 
dose effects of nicotine on these dependent measures, and whether those effects were 
modulated by strain and treatment cycle.  
Pre-feeding effects. Separate 2 × 2 × 2 (strain × cycle × feeding status: not pre-
fed at vehicle vs. pre-fed) mixed-design ANOVAs were conducted on median latencies 
and estimates of P and θ to establish the effects of pre-feeding on these dependent 
measures, and whether such effects were modulated by strain and treatment cycle. This 
analysis was intended to identify effects related to a potential nicotine-induced reduction 
in appetite (Dandekar et al. 2011; Wellman et al. 2005). Nicotine effects that matched 
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pre-feeding effects were discounted as potentially related to appetite reduction and not to 
performance enhancement. 
Schedule effects on latencies. Separate 2 × 2 × 2 (strain × schedule: FMI 0.5-s 
vs. 6-s on 0.6 mg/kg in second cycle; treatment: no-treatment vs. treatment day) mixed-
design ANOVAs were conducted on post-R and post-N latencies to establish whether 
strain and nicotine effects on latency were modulated by the length of the criterial waiting 
time. Only the second cycle of 0.6 mg/kg FMI 6-s treatment was used in this comparison 
to minimize the confound between schedule and order effects (FMI 6-s was implemented 
before FMI 0.5-s, see Figure 1).  
Stability of rate of reinforcement. Rate of reinforcement was measured as the 
number of reinforcers obtained per 60-min session. Although the maximum number of 
reinforcers obtainable in a session was 150 pellets, no rat reached this limit in any 
experimental session. The conjunctive VI schedule was expected to keep rate of 
reinforcement relatively constant across experimental manipulations. Stability of rate of 
reinforcement was tested by conducting a 2 × 2 × 4 (strain × cycle × dose) and a 2 × 2 × 2 
(strain × cycle × feeding status) mixed-design ANOVAs, with reinforcers per session as 
the dependent measure. 
Coefficient of variation. The estimation of the coefficient of variation (CV) of 
timed IRTs is often included as part of the analysis of FMI performance (Sanabria and 
Killeen 2008). Higher CV is indicative of less precise timing (Sanabria and Killeen 
2008). In this study we monitored CV across manipulations, but do not report it because 
baseline timing is not less precise in SHR than in WKY (Orduña et al. 2009; Orduña et 
al. 2008; Sanabria and Killeen 2008). This null finding was replicated here in the vehicle 
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condition, CVSHR = 0.18 +/- 0.01, CVWKY = 0.20 +/- 0.01. Thus, SHR does not appear to 
be an adequate model of timing deficits in ADHD (Toplak et al. 2006); effects of nicotine 
in this domain are, therefore, uninterpretable. 
 
Results 
Temporal Regulation Parameters 
In all conditions the distribution of IRTs were well described by a mixture of two 
underlying distributions, one gamma (timed IRTs) and one exponential (non-timed IRTs) 
(Eq. 1). Figure 2 illustrates the goodness-of-fit of this model to performance under 
vehicle and under the highest dose of nicotine, 0.6 mg/kg.  
 
Figure 2.  Mean cumulative frequency distributions of IRTs produced by SHR (top) and 
WKY (bottom) after s.c. injections of vehicle (circles) and 0.6 mg/kg nicotine (downward 
triangles). Data are organized in 39 bins, each containing approximately equal number of 
IRTs. Dotted lines are fits of the Temporal Regulation (TR) model of response inhibition 
capacity (Eq. 1). 
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Nicotine effects. A significant main effect of nicotine dose was observed on the 
proportion of correct IRTs, F(3,63) = 4.23, p = .009. Post hoc paired-sample t-tests 
revealed that all doses of nicotine reduced the proportion of correct IRTs, from an 
average of 51% at baseline to 33-36% under nicotine; t(22) ranged between 2.25, p = 
.035, and 3.00, p = .007. No significant effect of nicotine dose or strain was observed on 
the proportion of correct IRTs reinforced, which was on average 54%. 
Figure 3 shows the effects of strain and dose on estimates of θ and P. A 
significant main effect of dose on θ estimates was observed, F(3, 63) = 4.64, p = .005. 
Post hoc paired-samples t-tests revealed that, relative to vehicle, all doses of nicotine 
significantly reduced θ; t(22) ranged between 2.58, p = .017, and 3.31, p = .003. 
Significant strain × dose interaction effects on estimates of P were observed, F(3, 63) = 
5.05, p = .003. Post hoc t-tests on P revealed that it was (a) significantly higher for SHR 
than WKY on 0.1 mg/kg nicotine, t(21) = 2.33, p = .030, (b) significantly higher for SHR 
on 0.1 and 0.3 mg/kg nicotine than on vehicle, t(11) = 4.41, p = .001, and t(11) = 4.05, p 
= .002, respectively, and (c) significantly higher for WKY on 0.3 and 0.6 than on vehicle, 
t(10) = 2.79, p = .019, and t(10) = 2.64, p = .024. Overall, these results suggest that 
nicotine reduced response inhibition capacity, but dose-dependently increased the 
sensitivity to the temporal contingencies of reinforcement, requiring a lower dose for the 
latter improvement in SHR.  
Pre-feeding effects. Figure 3 shows the effects of pre-feeding (PF) on estimates 
of θ and P. A significant strain × cycle × feeding status interaction effect was observed 
on θ estimates, F(1, 21) = 5.61, p = .028. A separate analysis was conducted on θ 
estimates at each cycle. No significant effect of strain or feeding status was observed on θ 
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in either cycle, suggesting that the 3-way interaction effect on θ was an effect of cycle 
modulated by strain and feeding status. No significant effects of strain, cycle, or feeding 
status were observed on P.  
 
Figure 3. Mean estimates of θ (top) and P (bottom) for SHR (solid circles) and WKY 
(open circles) rats across vehicle (Veh), 0.1, 0.3, and 0.6 mg/kg s.c. nicotine (left of 
vertical dashed line) and pre-feeding (PF; right of vertical dashed line). *Significant 
difference between dose and Veh. §Significant simple main effect of strain at a dose level. 
†Significant difference between dose and Veh in SHR. ‡Significant difference between 
dose and Veh in WKY. Symbols are repeated with lower p-values (i.e., *p < .050, **p < 
.010, ***p < .001). A significant strain × cycle × feeding status interaction effect was 
observed on θ, but no significant main or interaction effect of strain or feeding status on θ 
were observed in either cycle. All doses of nicotine reduced estimates of θ relative to 
Veh. Nicotine increased estimates of P in a dose-dependent manner and differentially 
across strains. The nicotine dose-response curve of P was shifted leftwards in SHR 
relative to WKY.  
 
 
   26 
Latencies 
Nicotine effects. Figure 4 (left) shows the effects of strain and dose on post-R and 
post-N latencies. Significant effects of dose on post-R and post-N latencies were 
observed [post-R: F(3, 63) = 19.83, p < .001; post-N: F(3, 63) = 28.16, p < .001]. Post 
hoc paired-sample t-tests revealed that all doses of nicotine significantly shortened post-R 
and post-N latencies relative to vehicle; t(22) ranged between 2.36, p = .027, and 8.21, p 
< .001. No significant effect of strain was observed. Thus, regardless of strain or of the 
outcome in the preceding trial, even the lowest dose of nicotine was effective in reducing 
the time between trial onset and first lever press. 
Pre-feeding effects. Figure 4 (PF) shows the effects of strain and feeding status 
on post-R and post-N latencies. Significant main effects of feeding status on post-R and 
post-N latencies were observed [post-R: F(3, 63) = 20.08, p < .001; post-N: F(3, 63) = 
62.20, p < .001]. All latencies were roughly 2 s longer when rats were pre-fed. No 
significant strain × feeding status interaction effect was observed. Thus, regardless of 
strain or of the outcome of the preceding trial, pre-feeding increased the time between 
trial onset and first lever press. 
Schedule effects. Figure 4 (right) shows the effects of an s.c. injection of 0.6 
mg/kg on FMI 0.5-s and FMI 6-s performance. Significant main effects of schedule and 
nicotine were observed in both post-R [respectively: F(1, 21) = 61.56, p < .001; F(1,21) = 
27.92, p < .001] and post-N latencies [respectively: F(1,21) = 4.58, p = .044; F(1,21) = 
51.06, p < .001]. No significant effect of strain or interaction effect was observed. These 
results suggest that the nicotine-induced shortening of latencies was not schedule-
dependent, and was observable even when reinforcement was minimally delayed. 
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Figure 4.  Mean median latencies to the initial response across nicotine and pre-feeding 
(PF) treatment conditions (left panel) and across FMI schedules (right panel; FMI 6-s 
data is from cycle 2) for SHR and WKY rats. “Post-R” denotes the latencies following 
reinforced trials; “Post-N” denotes latencies following non-reinforced trials. *Significant 
difference between dose and Veh. #Significant main effect of FMI schedule, +Significant 
main effect of nicotine relative to no-treatment (day preceding injection). Symbols are 
repeated with lower p-values (i.e., *p < .050, **p < .010, ***p < .001). Nicotine and shorter 
FMI target time reduced median post-R and post-N latencies; pre-feeding increased 
median post-R and post-N latencies. 
 
Stability of Rate of Reinforcement 
A significant strain × dose effect on rate of reinforcement was observed, F(3,63) = 
2.84, p = .045. Post hoc paired-sample t-tests revealed that WKY obtained fewer 
reinforcers under 0.6 mg/kg nicotine than under vehicle, t(10) = 3.29, p = .008. This 
means that the effect of nicotine on WKY performance was confounded with the effects 
of reduced rate of reinforcement only at the highest dose. At other doses in WKY and all 
doses in SHR, these effects were not confounded.  
A significant strain × cycle × feeding status effect on rate of reinforcement was 
observed, F(1,21) = 310.42, p = .004. Post hoc t-tests were conducted separately in each 
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cycle. Post hoc comparisons revealed that, in the second cycle, pre-feeding substantially 
reduced the rate of reinforcement of WKY relative to no pre-feeding, t(10) = 2.98, p = 
.014, and relative to pre-fed SHR, t(21) = 2.97, p = .007.  
 
Discussion 
Nicotine and Response Inhibition  
The acute administration of nicotine reduced estimates of θ similarly for SHR and 
WKY (Figure 3). This result suggests that acute nicotine reduces response inhibition 
capacity in both strains. Although this finding is inconsistent with our expectations, it is 
consistent with nicotine-induced reductions in IRTs observed in DRL studies using 
Sprague Dawley rats (Kirshenbaum et al. 2008, 2009, 2011). Performance in DRL 
schedules cannot be readily interpreted in terms of response inhibition capacity, because 
it is also sensitive to reinforcer-efficacy manipulations (e.g., reinforcer magnitude; 
Doughty and Richards 2002). In contrast, estimates of θ are not significantly sensitive to 
changes in reinforcer efficacy via pre-feeding (Figure 3). Yet, nicotine also appears to 
reduce θ, suggesting that the effect of nicotine on DRL performance may not be solely 
explained on the basis of enhanced reinforcer efficacy. 
An alternative account of our results would suggest that reduced estimates of θ 
resulted from a faster internal clock under acute nicotine (Hinton and Meck 1996). 
Intervals trained without nicotine may be perceived as being longer under nicotine, thus 
yielding shorter timed IRTs when nicotine was acutely administered. The accelerative 
effects of nicotine on timing, however, have only been demonstrated using the peak 
interval method (Hinton and Meck 1996; Meck 2007), which is vulnerable to 
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confounding motivational effects (Galtress and Kirkpatrick 2009; Ludvig et al. 2011; 
Plowright et al. 2000; Sanabria and Thrailkill 2009). Timing estimates that are more 
robust to motivational manipulations, such as those obtained from the temporal bisection 
procedure (Galtress and Kirkpatrick, 2010), do not suggest an accelerative effect of 
nicotine on the internal clock (Ward et al. 2009). These findings do not support an 
explanation of nicotine-induced effects on θ based on timing mechanisms. 
Neither changes in reinforcer efficacy nor changes in rate of reinforcement can 
explain nicotine-induced reductions in estimates of θ. Pre-feeding did not have a 
significant effect on estimates of θ (Figure 3), but it increased latencies, an effect 
opposite that of nicotine. The robustness of θ to the pre-feeding manipulation suggests 
that, consistent with prior findings (Mechner and Guevrekian 1962), mean timed IRTs are 
robust against changes in reinforcer efficacy. Relative to baseline, rate of reinforcement 
was significantly lower only for WKY at the highest dose of nicotine. The stability of rate 
of reinforcement in both strains across most conditions was primarily due to the 
conjunctive VI schedule of reinforcement that imposed a minimum (but variable) amount 
of time between reinforcers. The limited effect of nicotine on rate of reinforcement 
cannot account for reductions in estimates of θ in both strains at every dose of nicotine. 
Thus, it appears that nicotine-induced reductions in estimates of θ reflect a nicotine-
induced reduction in the capacity of both SHR and WKY to withhold a reinforced 
response.  
Given that nicotine reduces response inhibition capacity so consistently in rodent 
models, it is unclear why the effects of nicotine on response inhibition capacity appear to 
vary so much among human studies. The key to these inconsistencies may be the 
   30 
underlying processes assessed by divergent methodologies. For instance, nicotine-
induced improvements in human response-inhibition capacity are primarily observed in 
the stop-signal task and in the Stroop task (Potter et al. 2012; Potter and Newhouse 2008; 
Potter and Newhouse 2004; Wignall and de Wit 2011). In these tasks, the behavior to be 
withheld is prepotent because it is either already initiated (stop signal task) or because it 
is strongly associated with a present stimulus (Stroop task). In contrast, most rodent 
paradigms, including DRL and FMI schedules, are based on behavior that is potentiated 
by its consequences. Nicotine has detrimental effects on performance in analogous tasks 
in humans, such as the biased visual discrimination task used by Barr et al. (2008).  
The absence of strain effects on estimates of θ at baseline tempers our 
interpretation of the measure of response inhibition capacity obtained from FMI 
performance. To the extent that θ reflects response inhibition capacity, and SHR models 
inhibitory deficits associated with ADHD, lower estimates of θ would be expected in 
SHR relative to WKY. This difference between strains has been observed systematically 
in the DRL (Ferguson et al. 2007, Orduña et al. 2009; Sagvolden and Berger 1996, 
Sanabria and Killeen 2008; van den Bergh et al. 2006), but was not observed in the 
present study using the FMI. It is thus likely that procedural differences between FMI and 
DRL schedules are responsible for these divergent results. Various features of the FMI—
the longer resting period between withholding trials, the response-initiated nature of these 
trials, the separation of initial and terminal responses—may facilitate the response-
withholding performance of SHR. 
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Nicotine and reinforcer efficacy 
Mechner and Guevrekian (1962) demonstrated that FMI latencies, but not IRTs, 
are sensitive to reinforcer deprivation. Our results are consistent with those findings, 
showing that pre-feeding increased latencies regardless of strain and of the outcome of 
the preceding trial (i.e., post-R vs. post-N; Figure 4, left). These results support the 
interpretation of changes in latencies as reflecting changes in reinforcer efficacy. The 
reduction in latencies following nicotine administration (Figure 4, left) thus suggests that 
nicotine enhanced the reinforcing efficacy of sucrose pellets. These data are consistent 
with reports of nicotine-induced enhancement of reinforcer efficacy for appetitive 
reinforcers or food-related cues (see Donny et al. 2011) in both rats (Grimm et al. 2012; 
Raiff and Dallery 2006; Wing and Shoaib 2010) and humans (Epstein et al. 1992; Perkins 
1992). 
In principle, however, it is possible that the reduction in latencies following 
nicotine administration reflects a nicotine-induced reduction in the sensitivity to the delay 
of reinforcement. Prior research (Morgan 1972) and the positive relationship between 
latencies and FMI target time (0.5 s vs. 6 s; Figure 4), support the notion that latencies are 
sensitive to delay of reinforcement. If nicotine effects on latencies were mediated by 
changes in sensitivity to delay of reinforcement, it would be expected that the elimination 
of the delay of reinforcement would also eliminate the effect of nicotine on latencies. 
Contrary to that expectation, however, nicotine produced shorter latencies even in FMI 
0.5 s, when delay to reinforcement was minimal (Figure 4, right panels). Such an effect 
supports the hypothesis that changes in latencies induced by nicotine reflect changes in 
reinforcer efficacy and not in sensitivity to the delay of reinforcement. 
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Nicotine and sensitivity to timing contingencies 
In all conditions the distribution of IRTs were well described by a mixture of two 
underlying distributions, one gamma (timed IRTs) and one exponential (non-timed IRTs) 
(Eq. 1, Figure 2). Generally, more than 90% of the IRTs were timed, signified by 
parameter P. The remaining 10% of intervals (1-P) appear to be produced absent of the 
control of the timing contingencies, as they are produced at a constant rate. Although it 
has not been explicitly evaluated in the FMI schedule, this loss of control by the 
contingencies of reinforcement may be attributed to lapses in attention (Killeen et al. 
2013; Sagvolden et al. 1998).  
In the present study, the proportion of timed intervals did not differ significantly 
at baseline (vehicle) between SHR and WKY (Figure 3, bottom). This lack of significant 
baseline differences has also been observed in paradigms designed to assess sustained 
attention in rodents, such as the 5-CSRTT (van den Bergh et al. 2006) and the visual 
stimulus position discrimination task (Thanos et al. 2010). The evidence available 
suggests that the SHR is not an adequate model of ADHD-related deficits in sustained 
attention. 
Nevertheless, the effects of nicotine on P may be informative.  It was observed 
that P increased following nicotine administration, tracing an inverted-U dose response 
function that peaked at a lower dose for SHR (0.1 mg/kg) than for WKY (0.3 mg/kg; 
Figure 3). This effect suggests that, relative to WKY, SHR required a lower dose of 
nicotine to increase the proportion of timed IRTs. If P were to be interpreted in terms of 
attentional processes, these results would be the opposite of what would be expected. 
This is because the SHR, compared to WKY, has fewer α4β2 nicotinic receptors 
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(Wigestrand et al. 2011), which appear to mediate the enhancement of sustained attention 
in rodents induced by nicotine (Rezvani et al. 2011; Young et al. 2013). Furthermore, 
estimates of P do not appear to increase with MPH treatment in rats (Hill et al. 2012), 
even though past research has shown that MPH enhances sustained attention in both rats 
(Paine et al. 2007) and humans (Epstein et al. 2006; Riccio et al. 2001). A potential 
explanation to these seemingly contradictory findings requires that nicotine and MPH 
enhance sustained attention through different mechanisms (Levy and Hobbes 1996; 
McGaughy et al. 1999), and P indexes a nicotine-sensitive attention-like process that is 
not necessarily mediated by α4β2 nicotinic receptors. Although it is yet unclear what 
neural processes are indexed by P, these processes are likely to have implications in the 
research and treatment of attentional deficits. 
Conclusion 
 This investigation provides the first evidence, in an animal model of ADHD, for 
nicotine-induced reduction in response inhibition capacity that is not confounded with 
reinforcer-efficacy effects. In particular, our data suggest that nicotine hinders the 
capacity of rats to withhold a response that has been instrumentally reinforced. This result 
undermines the hypothesis that smoking among individuals with ADHD is facilitated by 
an ameliorating effect of nicotine on response inhibition deficits.  
 Acute nicotine increased the degree to which rats responded to reinforcement 
contingencies. This effect peaked at a lower dose for the animal model of ADHD (0.1 
mg/kg) than for its control (0.3 mg/kg). Along with observations from past research and 
pre-feeding manipulations, it suggests that the mechanism by which nicotine enhances 
the sensitivity to reinforcement contingencies involve neither α4β2 nicotinic receptors—
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which are often involved in sustained attention—nor motivational mechanisms on which 
MPH appear to operate (Levy and Hobbes 1996). Future research may unveil the specific 
mechanisms supporting this effect.  
Footnote 1 
The VI schedule was implemented as follows: A timer ran throughout the session. 
Reinforcement became available when the timer completed a specified interval, with one 
exception: if the interval elapsed after the initial response, reinforcement was not 
available until the subsequent trial. After each reinforcer, the timer was reset and a new 
interval was specified. If a correct response was made before reinforcement became 
available, the rat was exposed to the 3kHz tone, but sucrose reinforcement was withheld. 
Intervals were specified by sampling without replacement from a 12-item Fleschler-
Hoffman distribution (Fleshler & Hoffman, 1962). The VI-schedule requirement 
progressed in daily succession (9, 15, 20, 30 s), until all rats were performing at VI 30-s 
and t = 6 s.  The VI schedule was implemented to reduce the between-subject variability 
in rate of reinforcement that would otherwise result from unequal performance. With this 
control in place, differences in performance could be reliably attributed to the 
experimental manipulation and not to differences in rate of reinforcement. 
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CHAPTER 3 
EFFECTS OF CHRONIC NICOTINE ON RESPONSE INHIBITION AND FOS 
ACTIVATION IN SPONTANEOUSLY HYPERTENSIVE AND WISTAR KYOTO 
RATS 
 Smoking remains the leading cause of preventable death in the United States, and 
early initiation is associated with greater difficulty quitting.  Among adolescent smokers, 
those with attention-deficit hyperactivity disorder (ADHD), characterized by difficulties 
with impulsivity and inattention, smoke at nearly twice the rate of their peers (Lambert 
and Hartsough 1998; Milberger et al. 1997).  Although cigarette smoking is highly 
addictive, nicotine is relatively weak primary reinforcer (Chaudhri et al., 2006; Palmatier 
et al., 2006, 2007), prompting research on other potential targets that maintain smoking, 
including the potential benefits of nicotine on attention (Barr et al., 2008; M Ernst, 
Heishman, Spurgeon, & London, 2001; Warburton & Mancuso, 1998), inhibition (Potter 
& Newhouse, 2004, 2008), and reinforcer efficacy (Chaudhri et al., 2006; Palmatier et al., 
2006, 2007; Raiff & Dallery, 2006).  The present study examines the effects of a chronic 
subcutaneous (s.c.) nicotine injections (0.3 mg/kg) on response inhibition and brain 
activation in an animal model of ADHD, the spontaneously hypertensive rat (SHR).  
Compared to acute effects, the effects of chronic nicotine administration on 
behavioral measures of response inhibition have received less attention.  However, the 
majority of existing data seems to suggest that chronic nicotine hinders performance in 
response inhibition tasks.  Levin et al. (2001) administered transdermal nicotine patches 
to non-smokers with and without ADHD for four weeks, but failed to find significant 
effects on measures of response inhibition obtained from the continuous performance 
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task.  In rodents, chronic nicotine has been shown to increase premature responding in the 
5-CSRTT (Amitai & Markou, 2009; Blondel, Sanger, & Moser, 2000; Blondel, Simon, 
Sanger, & Moser, 1999; Hahn, Shoaib, & Stolerman, 2002; Semenova, Stolerman, & 
Markou, 2007), well as in the differential reinforcement of low rates (DRL) schedule 
(Kirshenbaum et al., 2008).  In a rodent adaptation of the Go/No-go task, chronic nicotine 
decreased the proportion of correct “No-go” trials (Kolokotroni, Rodgers, & Harrison, 
2012).  In a delay discounting paradigm, chronic nicotine increases impulsive choice 
(Dallery & Locey, 2005; Kayir, Semenova, & Markou, 2014), with deleterious effects 
observed 30 days post-nicotine treatment (Dallery & Locey, 2005).  Although delay 
discounting is a measure of impulsive choice, not response inhibition, both measures are 
tied to impulsivity and appear to be sensitive to the effects of nicotine.  
Previously, we demonstrated that acute nicotine administration was detrimental to 
response-withholding performance in the fixed minimum interval (FMI) schedule of 
reinforcement (Mazur, Wood-Isenberg, Watterson, & Sanabria, 2014).  FMI schedules 
require subjects to wait a specified duration between responses in order for reinforcement 
to be delivered.  Waiting intervals are initiated with a lever press, and terminated with a 
head entry into the food hopper.  Terminal responses that occur prior to the criterial 
waiting time are deemed premature, i.e., impulsive.  The FMI schedule is similar to other 
response-withholding tasks that invoke a waiting requirement, such as DRL.  However, 
waiting intervals generated in FMI are less susceptible to motivational confounds (Hill et 
al., 2012; Mazur et al., 2014), and unlike other rodent response-withholding tasks, FMI 
schedules are capable of detecting benefits of methylphenidate on response inhibition 
(Hill et al., 2012). 
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The present study aimed to expand the findings of Mazur et al. (2014) to the 
effects of chronic nicotine administration—which may differ from effects of acute 
dosing—on FMI performance.  The unique action of acetylcholine nicotinic receptors 
(nAChRs) may lead to differences in performance between an acute or chronic dosing 
regimen.  Whereas exposure to agonists typically results in receptor downregulation, 
chronic nicotine exposure leads to an upregulation of nAChRs and increase in nicotine 
binding in the brain at a wide range of doses (0.45-5 mg/kg; Brennan, Lea, Fitzmaurice, 
& Truman, 2010; Wonnacott, 1990), an effect that may contribute to nicotine dependence 
(Picciotto, Zoli, Rimondini, & Léna, 1998).  Upregulation of nAChRs is only observed 
after repeated exposure to nicotine dosing, suggesting that chronic dosing may be 
advantageous for comparing the effects of nicotine in rodents to those of regular smokers. 
In humans, nicotine has a half-life of around 2 h, compared to 45 min in rats.  
This means that in rats receiving a daily injection schedule, nicotine is cleared entirely 
before the next injection.  These conditions make repeated daily injections an undesirable 
design for studying the effects of nicotine withdrawal, which typically requires more 
constant delivery of nicotine via osmotic mini-pumps (Matta et al., 2007).  Nonetheless, 
it has been shown that five daily subcutaneous (s.c.) injections of nicotine (0.1 and 0.4 
mg/kg) increased extracellular dopamine in the nucleus accumbens and increased 
spontaneous locomotor activity in rats, compared to a single injection of the same dose 
(Benwell & Balfour, 1992).  Cedex (1992) found that 12 repeated injections of nicotine 
(0.4 and 0.8 mg/kg) produced an increase in DA utilization in the mPFC, and enhanced 
locomotor effects in rats compared to a single dose.  Dallery and Locey (2005) 
administered daily s.c. injections of nicotine (0.3 mg/kg) and observed nicotine-induced 
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increases in impulsive choice that persisted 30 days after nicotine treatment was 
terminated.  Although repeated nicotine injections may not sustain blood concentrations 
high enough to induce dependence or withdrawal, neurochemical and long lasting 
behavioral effects can occur that would not be observable under and acute dosing 
regimen.   
Prolonged nicotine exposure may result in a reduction of some aversive effects, 
while enhancing rewarding effects.  Non-smokers who are administered nicotine report 
fewer positive effects compared to smokers, and more aversive effects such as decreased 
alertness, stronger symptoms of nicotine toxicity, and tremors (Foulds et al., 1997; 
Perkins et al., 1990; Soria et al., 1996).  Non-smokers report diminished aversive effects 
of nicotine with continued exposure (Brennan et al., 2010).  Thus, the atypical action of 
nicotine on nAChrs, combined with the initial aversive effects of nicotine exposure, 
support the notion that potentially beneficial effects of nicotine may only be visible after 
repeated dosing.   
 In order to determine if nicotine ameliorates response inhibition deficits, the 
present study employed an animal model of ADHD.  The SHR is the most extensively 
studied animal model of ADHD (Sagvolden, 2000; Sagvolden et al., 2009).  Compared to 
their normotensive control strain, the Wistar Kyoto (WKY), the behavior of the SHR 
appears to parallel core characteristics of ADHD, most consistently impulsivity (Evenden 
and Meyerson 1999, Ferguson et al. 2007, Orduña et al. 2009; Sagvolden and Berger 
1996, Sanabria and Killeen 2008; van den Bergh et al. 2006).  
Similarities between individuals with ADHD and SHRs are not limited to their 
behavioral profiles. SHRs show disregulation of mesocortical and mesolimbic DA 
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pathways, marked by reduced dopamine release and D2 receptor hypofunctioning (Q. Li 
et al., 2009; Linthorst, van Giersbergen, Gras, Versteeg, & de Jong, 1994; V. A. Russell, 
2002; V. a Russell, 2000; Viggiano, Vallone, Ruocco, & Sadile, 2003; Viggiano, 
Vallone, & Sadile, 2004).  Similarly, imaging data from patients with ADHD suggest a 
hypofunctioning dopamine system in the prefrontal cortex (PFC) and nucleus accumbens, 
evidenced by reduced availability of D2/D3 dopamine receptors and dopamine 
transporters (DAT; Volkow et al., 2007, 2009),  reduced activation of the PFC (Monique 
Ernst et al., 2003), and reduced frontal cortex volume (Krain & Castellanos, 2006).  
Genetic studies, although inconclusive, also point to links between ADHD and 
polymorphisms of dopamine receptor genes resulting under expression dopamine 
receptors (for review, see Faraone et al., 2005).   
 Functional activation in several relevant brain regions was examined via Fos-like 
immunoreactive (Fos-IR) labeling to determine differences in activation between SHR 
and WKY during the task, and to determine the effects of nicotine on activation in SHR.  
Sub-regions of the prefrontal cortex (PFC) and striatum were selected for their role in 
response inhibition, addiction, and influence on DA release in response to psychoactive 
drugs via the corticolimbic and mesolimbic pathways.  Specifically, the nucleus 
accumbens shell (AcbSh) was targeted because of its importance in modulating 
motivational salience, and establishing learned associations between motivational events, 
(Kalivas & Volkow, 2005).  The nucleus accumbens core (AcbC) was of interest due to 
its mediation of the expression of learned behaviors, and its anatomical association with 
the orbitofrontal cortex (OFC), a region implicated in inhibition and addiction.  (Eagle & 
Baunez, 2010; Rubia et al., 2009; Winstanley, Eagle, & Robbins, 2006)  The OFC is also 
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critically involved in compulsive drug taking and in motivation by stimuli predicting drug 
availability (Kalivas & Volkow, 2005).  Lesions to the infralimbic cortex (ILC) are 
associated with increases in impulsive responding in the 5-CSRTT (Winstanley et al., 
2006), and nicotinic receptors in the ILC are suggested to play a critical role in mediating 
the effects of nicotine on impulsivity (Tsutsui-Kimura et al., 2010). 
The present study examined the effects of a chronically administered systemic 
injection of a moderate dose of nicotine (0.3 mg/kg) on the response withholding 
performance of the SHR in a FMI schedule of reinforcement.  The selected dose is within 
the range of previous studies using repeated subcutaneous injections to examine effects of 
nicotine on operant behavior (Dallery & Locey, 2005; Kirshenbaum et al., 2008), and 
falls well within the range of typical systemic doses used in behavioral research (approx. 
0.05-0.8 mg/kg; Matta et al., 2007).  Also, 0.3 mg/kg acute nicotine produced the most 
pronounced behavioral effect in a previous study using an FMI schedule (Mazur et al., 
2014).   
Although the majority rodent research suggests that nicotine induces response 
inhibition deficits, not alleviates them, the use of a rodent task that is capable of detecting 
beneficial effects of stimulants on response inhibition (Hill et al., 2012) may be useful for 
studying the effects of chronic nicotine.  To the extent that SHR performance in FMI 
schedules models inhibitory deficits related to ADHD, timed waiting intervals were 
expected to be shorter in SHR than in WKY. To the extent that a chronic nicotine 
regimen alleviates inhibitory deficits, the duration of timed waiting intervals was 
expected to increase in SHR after extended exposure to nicotine.  In terms of functional 
activation, it was be expected that compared to WKY, SHR would show a 
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hypofunctioning prefrontal system, similar to what is observed in humans with ADHD, 
and that repeated exposure to nicotine would facilitate activation in the nucleus 
accumbens.  Thus, the experiment was designed to make two important comparisons: 
baseline differences between SHR and WKY, and the effects of nicotine on SHR. 
 
Method 
Subjects 
Thirty male rats, 20 Spontaneously Hypertensive Rats (SHR/NCrl) and 10 Wistar 
Kyoto (WKY/NHsd), arrived on post-natal day (PND) 25 and were pair-housed 
according to strain.  Subjects were maintained on a reverse light cycle (lights out 0700 to 
1900 hours), with daily sessions beginning at 0800 hours.  Once healthy weights were 
established, the duration of access to food was reduced daily from 24 h to 18 h, 12 h, and 
finally 1 h post-session.  Water was available in the home cages ad libitum throughout the 
duration of the experiment. 
 
Apparatus 
Experiments were conducted in 10 MED Associates (St. Albans, VT) modular 
test chambers (three chambers were 305 mm long, 241 mm wide, and 210 mm high; 
seven chambers were 305 mm long, 241 mm wide, and 292 mm high), each enclosed in a 
sound- and light-attenuating box equipped with a ventilating fan. The front and back 
walls and the ceiling of the test chambers were made of Plexiglas; the front wall was 
hinged and served as a door to the chamber. One of the two aluminum side panels served 
as a test panel. The floor consisted of thin metal bars positioned above a catch pan. A 
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square opening (51 mm sides) located 15 mm above the floor and centered on the test 
panel provided access to the hopper (MED Associates, ENV-200-R2M) and was 
furnished with a head entry detector (ENV-254-CB). Each activation of a dispenser 
delivered a single 45-mg sucrose pellet (TestDiet, Richmond, IN) to the hopper. A 
multiple tone generator (MED Associates, ENV-223) was used to produce 3 kHz tones at 
approximately 75 dB through a speaker (MED Associates, ENV-224AM) centered on the 
top of the wall opposite to the test panel, 52 mm from the ceiling of the chamber. Two 
retractable levers (ENV-112CM) flanked the food hopper, and three-color light stimuli 
(ENV-222M) were mounted above each lever and could be illuminated yellow, green, 
and red. Lever presses were recorded when a force of approximately 0.2 N was applied to 
the end of the lever. The ventilation fan mounted on the rear wall of the sound-
attenuating chamber provided masked noise of approximately 60 dB. The test chambers 
could be dimly illuminated by a houselight located behind the wall opposite to the test 
panel. Experimental events were arranged via a Med-PC® interface connected to a PC 
controlled by Med-PC IV® software. 
 
Procedure 
Sessions were conducted once daily, 7 days a week. Training initiated with 
autoshaping, consisting of pairing lever insertion with the delivery of a sucrose pellet. 
Once all rats were responding reliably to the lever, FMI training began. During FMI 
sessions, reinforcement was contingent upon the rat successfully waiting a given interval 
of time. The waiting interval was initiated by a lever press, and terminated with a head 
entry into the food hopper. 
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Sessions began with a 300-s acclimation period, during which the chamber 
remained inoperative and dark. After the acclimation period, the start of each subsequent 
trial was signaled by the insertion of the lever and illumination of the house light. The 
first response on the lever resulted in the house light being turned off and the illumination 
of the 3-color stimulus lights, signaling the start of the waiting interval. Criterial waiting 
time t is the amount of time that had to pass between the initial lever press and the 
terminal head entry response in order for reinforcement to be delivered.  “Correct” 
responses were defined as terminal responses made after t had elapsed, and were 
reinforced with sucrose paired with a 3 kHz tone.  Premature “incorrect” responses (i.e., 
responses prior to t) were not reinforced.  All terminal responses resulted in the retraction 
of the lever and a 10-s blackout period, after which the lever was reinserted and the next 
trial began. Each session ended after 45 min or after a rat obtained 100 food pellets, 
whichever happened first. 
At the onset of training, the criterial waiting time (t) was set to 0.5 s, and 
increased by 1.25% for each correct response. The value of t was carried over from one 
session to the next until t = 6 s, and remained constant thereafter. Once the 6-s criterion 
had been established, a conjunctive variable interval (VI) schedule was introduced. The 
VI schedule was implemented as follows: A timer ran throughout the session. 
Reinforcement became available when the timer completed a specified interval, with one 
exception. If the interval elapsed after the initial response, reinforcement was not 
available until the subsequent trial. After each reinforcer, the timer was reset and a new 
interval was specified. If a correct response was made before reinforcement became 
available, the rat was exposed to the 3 kHz tone, but sucrose reinforcement was withheld. 
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Intervals were specified by sampling from a 12-item Fleschler-Hoffman distribution 
(Fleshler & Hoffman, 1962). The VI-schedule requirement progressed in daily succession 
(9, 15, 20, 30 s), until all rats were performing at VI 30-s and t = 6 s. The VI 30-s and 6-s 
criterial time were fixed across sessions for the remainder of the experiment.  As soon as 
the VI and criterial waiting time were fixed, a 12-s limited-hold was implemented upon 
lever extension. Waiting intervals longer than 12-s were recorded as ineffective responses 
and did not result in reinforcer delivery. 
The VI schedule was implemented to reduce the between-subject variability in 
rate of reinforcement that would otherwise result from unequal performance. With this 
control in place, differences in performance could be reliably attributed to the 
experimental manipulation and not to differences in rate of reinforcement.  A VI 30-s 
schedule meant that, regardless of performance, on average reinforcement was set up 
(i.e., was delivered with the next correct response) every 30 s. 
Throughout FMI training, two variables were tracked daily: Median latency to the 
initial response and mean waiting interval. Performance was evaluated for stability after a 
minimum of 10 sessions with t = 6 s and VI = 30 s. Performance was deemed stable 
when, within 5 consecutive days, the mean waiting interval and the mean median latency 
of each strain (a) did not change in the same direction for more than 2 consecutive days 
(b) did not vary by more than 1.5 s. Once stability was achieved by both strains, each rat 
received three daily injections of saline to acclimate them to the injection process before 
chronic nicotine treatment was initiated.  SHR were assigned into two treatment groups 
of 10 (SHR-NIC, SHR-Veh) such that baseline performance was roughly equivalent 
between groups. WKY rats constituted a single group (WKY-Veh). 
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Nicotine Regimen  
During the treatment phase, each rat received daily injections of either 0.3 mg/kg 
nicotine (SHR-NIC), or a saline solution (SHR-Veh, WKY-Veh), approximately 10 min 
prior to the start each session.  Injections were delivered subcutaneously, and the volume 
of each injection was matched to body weight such that each rat received 0.1 ml per 100 
g of body weight. Daily FMI sessions were identical to those just prior to the start of 
treatment (i.e., t = 6 s, and VI = 30 s). Treatment continued until stability criteria 
(identical to FMI training) were established. 
 
Dependent Measures  
The primary dependent measures were mean waiting interval and the latency to 
the first lever press in each trial. Latencies refer to the time elapsed between the lever 
presentation (start of the trial) and the first lever press. For analysis, latencies were 
classified into two categories based on the outcome the previous trial:  (1) latencies 
following correct reinforced trials, (2) latencies following unreinforced trials. The 
unreinforced category includes trials during which a correct response went unreinforced 
because the VI had yet to elapse. 
 
Temporal Regulation Model  
The Temporal Regulation (TR) model (Sanabria & Killeen, 2008) was applied to 
estimate parameters of the distribution of waiting intervals.  The TR model assumes that 
a mixture of two distributions—one gamma and one exponential—underlie the 
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distribution of waiting intervals.  Our primary index of response inhibition was θ, the 
mean of the gamma-distributed, timed waiting intervals.  Parameter P is the proportion of 
timed waiting intervals.  Increases in P reflect and increase in gamma distributed waiting 
intervals relative to exponentially distributed waiting intervals.  For a detailed 
explanation of the Temporal Regulation model and its parameters, see Appendix A. 
 
Tissue preparation and Fos immunohistochemistry 
To capture peak Fos protein expression (Nestler, Barrot, & Self, 2001; 
Sonnenberg, Macgregor-Leon, Curran, & Morgan, 1989), all rats were overdosed with 
sodium pentobarbital (100 mg/kg, i.p.) 115 min following placement in the chambers on 
the last day of FMI testing.  Rats were transcardially perfused with phosphate buffered 
saline (pH 7.4) and 4% paraformaldehyde (pH 7.4), and brains were removed and post-
fixed in 4% paraformaldehyde and stored at 4°C overnight. Brains were then 
cryoprotected in 15% and 30% sucrose over 2d, and stored at 4°C until sectioning. Brains 
were sectioned on a cryostat at 20 µm. Multiple series of slides were taken at each level 
of section for separate cresyl violet and immunohistochemistry staining procedures. 
Sections mounted on slides were then stored at -80°C until tissue processing. One series 
of slides was stained with cresyl violet to identify and confirm subregions of interest for 
Fos analysis. Another series of slides containing subregions of interest were processed for 
immunohistochemistry against Fos protein, which will be termed Fos-like 
immunoreactive (Fos-IR) labeling. Target sections were washed three times in 1x 
phosphate buffered saline (1xPBS, pH 7.4) and incubated in 5% normal goat 
serum/1xPBS/ 0.4% Triton X for 60 min at room temperature. Rabbit polyclonal 
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antibody (anti-Fos, Santa Cruz Biotechnology, sc-52) was utilized to recognize Fos in 
specific sections containing the nucleus accumbens core, nucleus accumbens shell, 
dorsolateral striatum, orbitofrontal cortex, and infralimbic cortex.  This antibody was 
used at a dilution of 1:2500 in 5% normal goat serum/1xPBS/ 0.4% Triton X.  Following 
incubation (48 h, 4°C), sections were incubated with avidin–biotin-peroxidase complex 
(Vectastain ABC kit) for 45 min, then washed again in 1xPBS and processed using DAB 
with nickel-intensification (DAB peroxidase substrate kit, Vector Laboratories). Brain 
sections from each experimental group were processed similarly throughout all stages of 
the procedure. This procedure was adapted from Nikulina et al. (2004) and used recently 
(Hoffman et al., 2013, 2014). 
 
Data Analysis 
Data from the final five days of the training and the subsequent 17 treatment days 
were included for analysis.  Median latencies and estimates of θ were log-transformed, 
and estimates of P were log-odds transformed. These transformations follow suggestions 
on the estimation of population parameters in a similar model by Cheung, Neisewander 
and Sanabria (2012). All dependent measures are reported as back-transformed mean ± 
SEM. P and θ were estimated for each rat using the method of maximum likelihood 
(Myung 2003).  
 Dependent measures where evaluated under baseline, acute nicotine, and chronic 
nicotine conditions.  The baseline condition was comprised from data collected over the 
final five days of FMI training.  Data collected from the first day of the treatment phase 
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were used to evaluate the effects of acute nicotine, and data from the final three days of 
treatment were used to evaluate chronic-nicotine effects.   
Model parameters for each condition were derived by pooling the waiting 
intervals across the sessions in that condition, and estimating a single set of parameters 
per condition for each rat.  Latencies were pooled identically to waiting intervals; the 
median latency of each rat served as the dependent measure.  
ANOVA was implemented to establish the statistical significance of the effects of 
strain (SHR-Veh vs. WKY-Veh) and nicotine (SHR-Veh vs. SHR-Nic) on latencies and 
model parameters.  Two separate ANOVAs were performed for each dependent measure.  
Effects of strain were evaluated only for groups receiving vehicle using a 2 x 3 strain 
(SHR-Veh, WKY-Veh) x condition (Baseline, Acute, Chronic) mixed design ANOVA.  
Effects of nicotine were evaluated only for SHR groups using a 2 x 3 treatment (SHR-
Veh, SHR-Nic) x condition mixed design ANOVA.  Only significant main effects of 
condition and significant interaction effects were followed by post hoc 2-tailed t-tests; 
only significant effects are reported. 
 Differences in Fos-IR labeling were analyzed using independent samples t-tests to 
evaluate effects of strain (SHR-Veh vs. WKY-Vehi) and nicotine (SHR-Veh vs. SHR-
Nic).  The Benjamini-Hochberg procedure (Thissen, Steinberg, & Kuang, 2002) was 
applied to adjust t-critical values to control for false discovery when using multiple 
comparisons.  
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Results 
 In all conditions the distribution of waiting intervals were well described by a 
mixture of two underlying distributions, one gamma (timed waiting intervals) and one 
exponential (non-timed waiting intervals). Figure 5 illustrates the goodness-of-fit of this 
model to performance under baseline (BL) and under the first injection of nicotine, 0.3 
mg/kg (Ac). 
 
Figure 5.  Mean relative frequency distributions of waiting intervals produced by the 
SHR-NIC group during baseline (BL; downward triangles) and under the first injection of 
nicotine (Ac; plus sign). Data are organized in 39 bins of 0.5 s, and lines represent mean 
fits of the Temporal Regulation (TR) model. 
 
Temporal Regulation Parameters 
Response inhibition performance, θ. Figure 6 depicts mean estimates of θ 
during baseline and drug treatment phases.  A 2 x 3 (drug x condition) ANOVA for 
effects of nicotine on θ under baseline (BL), acute nicotine (Ac), and chronic nicotine 
(Ch) conditions was not significant.  However, a post-hoc independent samples t-test for 
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effects of drug (SHR-NIC vs SHR-Veh) on mean values of θ over the entire course of the 
treatment period (17 injection days) revealed a significant decrease in θ in the SHR-NIC 
group (t(32)=10.3, p<.001).   
 
Figure 6.  Mean estimates of θ, an index of response inhibition, depicted by day (A) and 
pooled according to condition (B).  Baseline (BL) and chronic nicotine (Ch) estimates 
were derived from pooling data from the final five days of baseline, and from days 15-17 
of chronic nicotine treatment, respectively.  Acute nicotine (Ac) estimates were derived 
from data from day 1 of nicotine injections.   
 
Proportion of timed waiting intervals, P.  No significant effects were observed 
on estimates of P. 
Latency to initiate the waiting interval 
Figure 7 depicts the mean latency to initiate waiting intervals for each group.  For 
analysis, latencies were subdivided into two categories: latencies that occurred following 
a trial in which reinforcement was delivered (Post-R), and latencies that occurred 
following a trial in which reinforcement was not delivered (Post-N). 
Post-R latencies.  A significant drug x condition interaction was observed on 
SHR Post-R latencies (F(2)=4.390, p=.020).  Follow up post-hoc paired samples t-tests in 
the SHR-NIC group revealed that, compared to BL, Post-R latencies were significantly 
reduced in the Ac (t(9)=2.344, p=.044), and Ch (t(9)= 2.407, p=.039) conditions.  
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Post-N latencies.  A significant main effect of drug on Post-N latencies was 
observed (F(1)=5.581, p=.030).  Nicotine decreased Post-N latencies. 
 
Figure 7.  A. Mean of the median latency to the initial response, depicted by group.  
Post-R latencies (top) are latencies to initiate the waiting interval following reinforced 
trials, and Post-N latencies (bottom) are latencies following trials in which reinforcement 
was not delivered.  B. Baseline (BL) and chronic nicotine (Ch) estimates were derived 
from pooling data from the final five days of baseline, and from days 15-17 of chronic 
nicotine treatment, respectively. Acute nicotine (Ac) estimates were derived from data 
from day 1 of nicotine injections.   
 
 
Fos-IR Labeling 
 Figure 8 depicts Fos-IR labeling.  Independent-samples t-tests revealed 
significantly greater functional activation within the nucleus accumbens shell in SHR-
Veh than in SHR-Nic (t(15)=2.627, p=.019).  Functional activation in the OFC was 
greater in WKY than SHR (t(17)=2.244, p=.038), however the Benjamini-Hochberg 
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correction for false discovery rate adjusted α to .025, so this difference failed to meet the 
criterion for significance. 
  
Figure 8.  Fos-positive nuclei/mm2  depicted by brain region.  AcbC=nucleus accumbens 
core, AcbSh=nucleus accumbens shell, DLS=dorsolateral striatum, ILC=infralimbic 
cortex, OFC= orbitalfrontal cortex.  *Denotes significant difference between groups; 
p<.05. 
 
Discussion 
The present study examined the effects of chronic nicotine exposure on the 
response withholding performance of SHR and WKY rats under a FMI schedule of 
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reinforcement.  The hypothesis, that repeated, long-term exposure to nicotine would 
improve response inhibition performance in SHR, an animal model of ADHD, was not 
supported.  An analysis of the effects of nicotine on θ over the course of the injection 
period (17 days) revealed a significant decrease in θ in the SHR-NIC group.  While this is 
opposite our predictions, it is in agreement with the majority of existing rodent research 
(Amitai & Markou, 2009; Blondel et al., 2000, 1999; Hahn et al., 2002; Kirshenbaum et 
al., 2008; Kolokotroni et al., 2012; Semenova et al., 2007).  The present findings also are 
inconsistent with the hypothesis that high prevalence of smoking among the ADHD 
population is due to nicotine’s ability to ameliorate ADHD-related inhibitory deficits. 
One potential interpretation of the present data is that reduced estimates of θ could 
result from a nicotine-induced speeding of the internal clock (Hinton and Meck 1996).  
However, such effect has only been observed in the peak interval procedure (Hinton and 
Meck 1996), and timing performance rapidly recovered to baseline after two days of 
nicotine administration.  The present data do not suggest a rapid recovery of baseline 
performance following nicotine treatment.  Furthermore timing estimates that are more 
robust to motivational manipulations, such as those obtained from the temporal bisection 
procedure (Galtress and Kirkpatrick, 2010), do not suggest an accelerative effect of 
nicotine on the internal clock (Ward et al. 2009).  Combined with evidence that chronic 
nicotine can increase appetite for sucrose in rats (Jias & Ellison, 1990), an explanation of 
nicotine-induced effects on θ based on timing mechanisms is not supported.   
It is important to note that the SHR did not display baseline response inhibition 
deficits relative to WKY.  This lack of strain differences was also observed on FMI 
schedules in a previous study (Mazur et al., 2014), and acute nicotine (0.1, 0.3, 0.6 
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mg/kg) produced equivalent decrements in both strains.  Testing the hypothesis that 
nicotine ameliorates response inhibition deficits hinges on the presence of deficits at 
baseline.  Nonetheless, it is unlikely that the detrimental effects of nicotine observed here 
would be reversed if SHR had performed worse than WKY.  Given the similarities 
between FMI and DRL schedules, it is interesting that SHR display robust response 
inhibition deficits in DRL procedures (Bull, Reavill, Hagan, Overend, & Jones, 2000; 
Ferguson et al., 2007; Orduña, Valencia-Torres, & Bouzas, 2009; Sagvolden & Berger, 
1996; Sanabria & Killeen, 2008; van den Bergh et al., 2006), but not in FMI.     
 The first injection of nicotine reduced the latency to initiate waiting intervals in 
SHR, regardless of whether or not reinforcement was delivered on the previous trial 
(Figure 7).  In the case of Post-R latencies, this effect was still observable at the end of 
the chronic condition.  The finding that nicotine reduces response latencies is consistent 
with data from FMI schedules (Mazur et al., 2014), as well as response latencies obtained 
from the 5-CSRTT (Blondel et al., 2000; Mirza & Stolerman, 1998; Semenova et al., 
2007; Stolerman, Mirza, Hahn, & Shoaib, 2000). 
 Evidence from Fos-IR labeling did not support our hypothesis that chronic 
nicotine would increase general activation in the nucleus accumbens. On the contrary, 
nicotine-treated SHR showed significantly less activation in the AcbSh than controls.  
Several studies targeting the AcbSh have provided evidence that chronic pretreatment 
with nicotine leads to an increase in DA availability compared to saline pretreatment 
(Benwell & Balfour, 1992; Cadoni & Di Chiara, 2000; Carboni, Bortone, Giua, & Di 
Chiara, 2000; Di Chiara, 2000; Nisell & Marcus, 1997).  Chronic nicotine has also been 
observed to increase Fos-IR labeling in the AcbSh (Nisell, Nomikos, Chergui, Grillner, & 
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Svensson, 1997; Salminen, Seppa, & Ga, 1999; Shim et al., 2001).  Although evidence 
suggests that chronic nicotine treatment leads to a reduced DA output compared to the 
initial nicotine exposure (Cadoni & Di Chiara, 2000; Carboni et al., 2000; Di Chiara, 
2000; Nisell & Marcus, 1997), others have found that chronic nicotine exposure 
potentiates the DA response in the AcbSh (Benwell & Balfour, 1992).  Nevertheless, we 
were unable to find published evidence of a nicotine-induced reduction in Fos-IR 
labeling.  Papa et al. (2002) found that repeated methylphenidate injections decreased DA 
binding sites in the AcbSh of the SHR.  Given the dysregulated dopamine system of the 
SHR (Q. Li et al., 2009; Linthorst et al., 1994; V. A. Russell, 2002; V. a Russell, 2000; 
Viggiano et al., 2003, 2004), the observed effect of nicotine on the AcbSh may be relatd 
to strain-specific characteristics of the SHR.  It is also important to note that unlike the 
studies mentioned above, the present study timed tissue collection to coincide with peak 
Fos expression during the final experimental FMI session.  Thus, in the nicotine-treated 
SHR group, Fos expression could result from exposure to nicotine or from exposure to 
the task, rendering results difficult to interpret.    
 Although the FMI schedule used did not detect response inhibition deficits in 
SHR, it seems clear that chronic nicotine administration does not provide a benefit for 
our marker of response inhibition performance (θ).  Further research is warranted to 
determine why SHR do not display response inhibition deficits in FMI, despite 
demonstrating robust deficits in DRL schedules.   
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CHAPTER 4 
PERFORMANCE OF SPONTANEOUSLY HYPERTENSIVE AND WISTAR KYOTO 
RATS ON EXTERNALLY- VS. SELF-PACED REPONSE WITHOLDING TASKS: 
EFFECTS OF ACUTE NICOTINE 
Attention-deficit hyperactivity disorder (ADHD), marked by difficulties with 
inhibition, hyperactivity, and attention, is among the most common childhood psychiatric 
disorders, affecting between 2% and 10% of children worldwide (Froehlich et al. 2007; 
Skounti et al. 2007).  Deficits in response inhibition are a core feature of ADHD,  defined 
by an inability to withhold prepotent responses, including those that have been previously 
reinforced (Aron & Poldrack, 2005; Barkley, 1997; Grant et al., 2005).  The 
spontaneously hypertensive rat (SHR) is the most common rodent model of ADHD, and 
is frequently employed in the study of response inhibition deficits.  However, a variety of 
behavioral tasks are available to assess response inhibition in rodents, with varying 
results.  Under certain conditions SHR show response inhibition deficits, and under 
others they do not.  Research suggests that children with ADHD perform better on 
externally paced tasks compared to self-paced tasks (Koschack, Kunert, Derichs, 
Weniger, & Irle, 2003; Sonuga-Barke, Taylor, & Heptinstall, 1992).  The present study 
reviews differences between several rodent response inhibition paradigms, and examines 
the contribution of self-pacing vs. experimenter-pacing to SHR performance on two 
variations of the differential reinforcement of low rates (DRL) schedule free-operant 
DRL (FO-DRL; Ferster & Skinner, 1957), and discrete-trials DRL (DT-DRL; F. Logan, 
1961). 
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DRL schedules require animals to wait a specified duration between consecutive 
responses in order to receive reinforcement.  Performance is measured by the ability to 
successfully wait between responses (i.e., respond at a sufficiently low rate), and is 
considered a measure of ‘waiting’ impulsivity (Eagle et al., 2008).  
Across a wide range of response inhibition indices (e.g., mean inter-response 
time, responses per reinforcer, peak latency,  mean timed waiting interval), SHR 
generally perform worse than WKY on FO-DRL schedules (Table 1).  This effect is 
observed regardless of age, which ranged from approximately post-natal day (PND) 50 to 
PND 260, or the criterial waiting time, which ranged from 5 to 72 s.  Of the seven FO-
DRL experiments listed, only one failed to find response inhibition deficits in SHR 
relative to WKY (Ferguson et al., 2007).  In this exceptional case, extended training (106 
sessions) and breeder selection (see Sagvolden et al., 2009) may have contributed to this 
divergence from the general trend.  
 
Table 1.  Performance of SHR and WKY rats on free operant DRL schedules 
Task Approx age Performace differences # sessions Author 
DRL-5 PND 260 LE, WKY > SHR NL Sanabria & Killeen (2008) 
DRL-10 PND 90 WIS, WKY > SHR 70 Orduña et al. (2009)  
DRL-10 PND 90 WIS, WKY > SHR 30 Orduña et al. (2009)  
DRL-10 PND 148 SD > SHR, WKY 106 Ferguson et al. (2007) 
DRL-16 PND 80 WKY > SHR 42 Sagvolden & Berger (1996) 
DRL-60 PND 260 LE, WKY > SHR NL Sanabria & Killeen (2008) 
DRL-60 NL WKY > SHR > SD 5 Bull et al. (2000) 
DRL-72 PND 50 WKY > SHR NL van den Bergh et al. (2006) 
Ages are best approximation of PND at the beginning of testing.  NL=not listed 
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It seems that FO-DRL schedules are suitable for observing response inhibition 
deficits in SHR.  This appears not to be the case for the fixed minimum interval (FMI) 
schedule of reinforcement (Mechner & Guevrekian, 1962).  Similar to DRL, FMI 
schedules require subjects to wait a specified interval between responses.  However, in 
FMI schedules the initial response differs from the terminal response (i.e., two different 
levers, or a lever press followed by a hopper beam break), whereas initial and terminal 
responses in DRL schedules are co-located (i.e. consecutive presses on a single lever, 
consecutive beam breaks).  Recent evidence showed that SHR on FMI 6-s schedules do 
not display response inhibition deficits relative to WKY (Mazur et al., 2014; Mazur et al., 
submitted).  This finding is surprising, considering that both schedules require animals to 
withhold responding for a given interval.   
Two major differences between FMI and FO-DRL schedules are that (1) in FO-
DRL schedules the target response for initial and terminal responses are the same, 
whereas in FMI they are not, and (2) FO-DRL is a free-operant procedure where multiple 
waiting intervals can be produced in rapid succession, whereas FMI is a discrete-trial 
procedure. This means that in FMI schedules each waiting interval produced is followed 
by an ITI such that only one waiting interval can be produced per trial.   
The difference between the free-operant arrangement in FO-DRL schedules and 
discrete-trials arrangement in FMI schedules may account for the absence of evidence of 
strain differences under FMI schedules.  In a free-operant design, subjects control the 
pace at which waiting intervals are generated.  Although subjects do not control the start 
of each waiting interval, their rate of responding dictates the rate at which waiting 
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intervals are produced.  Subjects are permitted to respond rapidly, producing a large 
number of short intervals.  This is contrary to a discrete-trials design, where the program 
places external limits on the pace at which waiting interval can be generated, via the ITI 
and resetting of the trial (see Figure 9 for schedule diagram). 
Research in humans with ADHD on self-paced vs. externally paced tasks suggests 
that when participants are permitted to control the pace of stimulus presentation, children 
with ADHD perform worse than controls, but when the pace of stimulus presentation is 
externally controlled by the experimenter, children with ADHD perform similarly to 
controls (Koschack, Kunert, Derichs, Weniger, & Irle, 2003; Sonuga-Barke, Taylor, & 
Heptinstall, 1992).  The differences between self-paced and externally paced performance 
is attributed to a faster response style, where children with ADHD respond more rapidly 
and spent less time attending to stimuli (Denckla, 1996; Koschack et al., 2003).   
A similar distinction may be made between FMI and FO-DRL. Two major 
differences between FMI and FO-DRL schedules are that (1) in FO-DRL schedules the 
target response for initial and terminal responses are the same, whereas in FMI they are 
not, and (2) FO-DRL is a free-operant procedure where multiple waiting intervals can be 
produced in rapid succession, whereas FMI is a discrete-trial procedure. This means that 
in FMI schedules each waiting interval produced is followed by an ITI such that only one 
waiting interval can be produced per trial.   
To test the hypothesis that response inhibition deficits in SHR are ameliorated by 
an externally-paced task, we implemented a discrete-trials DRL (DT-DRL) task that was 
as similar as possible to the FMI task used in past research (Mazur et al., 2014, 
submitted).  To our knowledge this is the first study to examine SHR vs. WKY 
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performance on a DT-DRL task.  To the extent that externally controlling the pace at 
which waiting intervals are generated contributes to improved performance in 
impulsive/hyperactive subjects, we expected SHR to perform equally well as WKY on a 
DT-DRL task.  For comparison, the same cohort of SHR and WKY were also exposed to 
a FO-DRL procedure.  In the case of FO-DRL, we expected SHR to perform markedly 
worse than WKY, evidenced by shortened mean waiting intervals.   
 
 
Figure 9.  Depiction of events from one reinforcer to the next for three operant 
schedules: FMI, discrete-trials DRL, and free-operant DRL; (WI=waiting interval).  
 
Methods 
Subjects 
Subjects were sixteen male rats, 8 Spontaneously Hypertensive Rats (SHR/NCrl) 
and 8 Wistar Kyoto (WKY/NHsd), post-natal day (PND) 50.  Subjects were pair-housed 
according to strain and maintained on a reverse light cycle (lights out 0700 h to 1900 h), 
with daily sessions beginning at 10 am.  Once healthy weights were established, the 
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duration of access to food was reduced daily from 24 h to 18 h, 12 h, and finally 1 h post-
session (given 30 min after the end of the session).  Water was available in the home 
cages ad libitum throughout the duration of the experiment. 
Apparatus 
Experiments were conducted in 10 MED Associates (St. Albans, VT) modular 
test chambers (three chambers were 305 mm long, 241 mm wide, and 210 mm high; 
seven chambers were 305 mm long, 241 mm wide, and 292 mm high), each enclosed in a 
sound- and light-attenuating box equipped with a ventilating fan. The front and back 
walls and the ceiling of the test chambers were made of Plexiglas; the front wall was 
hinged and served as a door to the chamber. One of the two aluminum side panels served 
as a test panel. The floor consisted of thin metal bars positioned above a catch pan. A 
square opening (51 mm sides) located 15 mm above the floor and centered on the test 
panel provided access to a dipper (MED Associates, ENV-202M-S) fitted with a cup 
(MED Associates, ENV-202C) that could hold 0.01 cc of a liquid reinforcer (33% 
sweetened condensed milk diluted in tap water; Great Value brand, Walmart, 
Bentonville, AK). The receptacle was furnished with a head entry detector (ENV-254-
CB).  A multiple tone generator (MED Associates, ENV-223) was used to produce 3 kHz 
tones at approximately 75 dB through a speaker (MED Associates, ENV-224AM) 
centered on the top of the wall opposite to the test panel, 240 mm above the floor of the 
chamber. Two retractable levers (ENV-112CM) flanked the food hopper, and three-color 
light stimuli (ENV-222M) were mounted above each lever and could be illuminated 
yellow, green, and red. Lever presses were recorded when a force of approximately 0.2 N 
was applied to the end of the lever. The ventilation fan mounted on the rear wall of the 
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sound-attenuating chamber provided masked noise of approximately 60 dB. The test 
chambers could be dimly illuminated by a houselight located behind the wall opposite to 
the test panel. Experimental events were arranged via a Med-PC® interface connected to a 
PC controlled by Med-PC IV® software. 
 
Procedure 
Sessions were conducted once daily, 7 days a week.  During all DRL sessions, 
reinforcement was contingent upon the rat successfully waiting a given interval of time 
between consecutive responses.  The criterial waiting time was 6 s; correct responses 
were reinforced with 5-s access to 0.01 ml of sweetened condensed milk. Premature 
incorrect responses were not reinforced.  All sessions began with a 300-s acclimation 
period, during which the chamber remained inoperative and dark. 
Discrete-trial DRL.  After the acclimation period, each trial began with the 
illumination of the house light and initiation of VT 9-s timer, sampled from a Fleshler-
Hoffman distribution (Fleshler & Hoffman, 1962).  Once the VT interval elapsed, the 
houselight was turned off, the right lever was inserted, and the 3-color stimulus lights 
above the lever were illuminated, signaling the start of the waiting interval.  The waiting 
interval was terminated with a head entry into the food hopper; lever presses were 
recorded but had no programmed effect.  The criterial waiting time t was the minimum 
amount of time that had to pass between the lever insertion and the terminal head entry 
response in order for reinforcement to be delivered.  Correct responses were defined as 
terminal responses made after t had elapsed since the initial response, and were 
reinforced with 5-s access to 0.01 ml of sweetened condensed milk. paired with a 0.5-s 
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3kHz tone.  Premature incorrect responses (i.e., terminal responses prior to t) were not 
reinforced.  All terminal responses resulted in the retraction of the lever and a 5.5-s 
blackout period, after which the lever was reinserted and the next trial began.  Each 
session ended after 45 min or after 150 sucrose pellets were delivered, whichever 
happened first. 
At the onset of DRL training, the criterial waiting time (t) was set to 0.5 s, and 
was increased by 1.25 percent after each correct response.  The value of t was carried 
over from one session to the next until t = 6 s, and remained constant thereafter.  Once the 
6-s criterion had been established, the probability of the availability of reinforcement for 
correct responses was changed from 100 percent to 40 percent: At the start of each trial, 
there was a 40 percent chance that reinforcement would be set up (i.e., available) for a 
correct response.  Once reinforcement was set up, its availability was carried over from 
trial to trial until a correct response was recorded.  This probability was reduced to 
mitigate the between-subject variability in rate of reinforcement that would otherwise 
result from unequal performance.  Thirty-two sessions were conducted. 
Nicotine administration.  After 32 sessions, a nicotine probe was conducted.  
Each rat was administered one subcutaneous injection of nicotine (0.3 mg/kg), and one 
subcutaneous injection of saline in a counterbalanced order, separated by four days.  Both 
injections were administered 5 min prior to the start of the session. 
 
Free Operant DRL. Four days after the last injections from the previous 
condition FO-DRL training began.  In this procedure, initial and terminal responses were 
both made by a lever press.  After the acclimation period, the left lever was inserted (note 
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that only the right lever was used in the previous condition).  The first response on the 
lever initiated the waiting interval; subsequent responses on the lever simultaneously 
terminated the current waiting interval and began a new one.   
At the onset of FO-DRL training, the criterial waiting time (t) was set to 0.5 s and 
was increased in the same manner described in the DT-DRL condition.  Premature 
responses did not end the trial or result in a timeout.  Instead, the waiting interval was 
reset and the lever remained extended until a waiting interval greater than 6 s was 
produced.  Correct responses were reinforced with 5-s access to 0.01 ml of sweetened 
condensed milk paired with a 0.5-s 3kHz tone.  Thirty sessions were conducted. 
Nicotine administration.  After 30 sessions, a nicotine probe was conducted.  
Each rat was administered one subcutaneous injection of nicotine (0.3 mg/kg), and one 
subcutaneous injection of saline in a counterbalanced order, separated by four days.  Both 
injections were administered 5 min prior to the start of the session. 
 
Temporal Regulation Model  
The Temporal Regulation (TR) model (Sanabria & Killeen, 2008) was applied to 
estimate parameters of the distribution of waiting intervals.  The TR model assumes that 
a mixture of two distributions—one gamma and one exponential—underlie the 
distribution of waiting intervals.  Our primary index of response inhibition performance, 
θ, represents the mean of the timed waiting intervals.  Parameter P is the proportion of 
timed waiting intervals.  Increases in P reflect and increase in gamma distributed waiting 
intervals relative to exponentially distributed waiting intervals.  For a detailed 
explanation of the Temporal Regulation model and its parameters, see Appendix A. 
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Data Analysis 
Individual waiting intervals from the final five days of testing were pooled and 
used for the analysis of strain differences. P and θ were estimated for each rat using the 
method of maximum likelihood (Myung 2003). Latencies were pooled identically to 
waiting intervals, and the median latency for each rat was used to calculate the group 
mean.  Strain differences were evaluated using an independent-samples t-test of the 
pooled values for each dependent measure.  Non-significant effects (p > .050) were not 
reported. 
Effects of nicotine were evaluated using a 2 x 2 mixed design ANOVA with strain 
(SHR vs. WKY) as the between-subjects factor and drug (Veh vs. NIC) as the within-
subjects factor.  
Results 
In all conditions, the distribution of waiting intervals was well described by a 
mixture of two underlying distributions, one gamma (timed waiting intervals) and one 
exponential (non-timed waiting intervals). Figure 10 illustrates the goodness-of-fit of this 
model to performance in the last five days of training (pooled). 
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Figure 10.  Mean relative frequency distributions of waiting intervals produced by the 
SHR (downward triangles) and WKY (plus sign) rats on DT-DRL (top) and FO-DRL 
schedules (bottom) schedules of reinforcement. Data are organized in 39 0.25-s bins, and 
lines represent fits of the Temporal Regulation (TR) model. 
 
Discrete-trials DRL 
Mean waiting interval.  Mean waiting intervals for each strain are depicted in 
Figure 11 (top).  Independent samples t-tests revealed a that mean waiting intervals were 
  
.02
.04
.06
.08
SHR
WKY
DT-DRL
0 2 4 6 8 10 12
  
.02
.04
.06
.08
FO-DRLR
el
at
iv
e 
Fr
eq
ue
nc
y
Waiting intervals (s)
   67 
significantly shorter for SHR than WKY over the last 5 days of non-injection sessions 
(t(14)=4.808, p<.001).  A 2 x 2 (strain x drug) repeated measures ANOVA revealed that 
nicotine significantly decreased mean waiting intervals (F(1,1)=16.729, p=.001). 
Response threshold, θ.  Independent samples t-tests revealed that θ was 
significantly lower in SHR relative to WKY over the last 5 days of non-injection sessions 
(t(14)=2.526, p= .024). A 2 x 2 (strain x drug) repeated measures ANOVA revealed a 
significant main effect of drug—nicotine significantly decreased mean waiting intervals 
(F(1,1)=8.177, p=.013). 
Proportion of timed waiting intervals, P.  An independent samples t-test for 
effects of strain revealed that P was significantly higher for WKY than SHR 
(t(14)=4.113, p=.001).  A 2 x 2 (strain x drug) repeated measures ANOVA only revealed 
a significant effect of strain (F(1,1)=9.309, p=.009) where WKY produced a larger 
proportion of gamma distributed waiting intervals.  
   68 
 
Figure 11.  Left panels depict mean waiting intervals (top), mean estimates of θ (middle) 
and P (bottom) for discrete-trial DRL sessions.  Right panels depict effects of veh and 0.3 
mg/kg injections.  *Denotes significant effect of group.  +Denotes significant effect of 
drug.  Symbols are repeated with lower p-values (i.e., *p < .050, **p < .010, ***p < .001) 
 
Free operant DRL 
Mean waiting interval.  Mean waiting intervals for each strain are depicted in 
Figure 12 (top). Independent samples t-tests revealed that SHR produced significantly 
shorter mean waiting intervals compared to WKY over the last 5 days of non-injection 
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sessions (t(14)=4.093, p= .001).  A 2 x 2 (strain x drug) repeated measures ANOVA 
revealed a significant main effect of drug (F(1,1)=18.580, p=.001), and a significant 
effect of strain (F(1,1)=26.935, p< .001).  Nicotine significantly decreased mean waiting 
intervals and SHR had significantly shorter mean waiting intervals than WKY. 
Response threshold, θ.  Independent samples t-tests revealed that θ was 
significantly lower in SHR relative to WKY over the last 5 days of non-injection sessions 
(t(14)=3.228, p= .006).  A 2 x 2 (strain x drug) repeated measures ANOVA revealed a 
significant main effect of drug (F(1,1)=13.436, p=.003), and a significant main effect of 
strain (F(1,1)=9.810, p= .007).  Nicotine significantly decreased estimates of theta, and 
SHR had significantly shorter estimates of theta than WKY. 
Proportion of timed waiting intervals, P. A 2 x 2 (strain x drug) repeated 
measures ANOVA revealed a significant main effect of drug (F(1,1)=8.165, p=.013).  
Nicotine decreased the proportion of timed waiting intervals. 
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Figure 12.  Left panels depict mean waiting intervals (top), mean estimates of θ (middle) 
and P (bottom) for free-operant DRL sessions.  Right panels depict effects of veh and 0.3 
mg/kg injections.  *Denotes significant effect of group.  +Denotes significant effect of 
drug.  Symbols are repeated with lower p-values (i.e., *p < .050, **p < .010, ***p < .001) 
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Discussion 
In both DRL schedules, SHR consistently produced shorter mean waiting 
intervals than WKY.  This finding supports previous evidence from SHR and WKY on 
FO-DRL schedules (Bull et al., 2000; Evenden & Meyerson, 1999; Ferguson et al., 2007; 
Orduña et al., 2009; Sagvolden & Berger, 1996; Sanabria & Killeen, 2008; van den 
Bergh et al., 2006), but is contrary to the hypothesis that SHR would perform better in an 
externally paced DT-DRL task.  Similarly, estimates of θ show that the response-
withholding performance of SHR was significantly worse than WKY, regardless of DRL 
schedule. Strain differences in performance under the DT-DRL schedule were also 
reflected in estimates of P (Figure 11, bottom).  This means that the shorter mean waiting 
intervals produced by SHR in DT-DRL were influenced by a significant increase in 
exponentially distributed responses (i.e., lower values of P).  This effect is visible in the 
mean distribution of waiting intervals produced in DT-DRL (Figure 11, top).  Notice the 
peak of the mean distribution of SHR waiting intervals is shorter than 2 s, and declines 
steadily with increasing durations.  This exponential pattern, combined with a lack of a 
peak around the criterial waiting time suggests that SHR may have been less sensitive to 
the contingencies of the timing task than WKY.  Although the majority of waiting 
intervals produced by WKY were below criterion, the mode of their distribution suggests 
that WKY were more sensitive to the contingencies of the task.   
Difficulties in acquisition may have arisen from the fact that, in DT-DRL, waiting 
intervals were initiated by the program—not the rat—and terminal responses were 
produced by a head-entry beam break into the hopper.  In this arrangement, the 
production of waiting intervals required rats to attend to cues signaling that the waiting 
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interval had been initiated by the program.  If rats failed to attend to the cues, and instead 
checked the hopper for food at random intervals, the distribution of intervals would 
closely resemble the exponential pattern produced by SHR in the DT-DRL condition.  
While the differential effect on SHR performance is certainly interesting, it seems that a 
DT-DRL task in which the initiation and termination of waiting intervals is controlled by 
the subjects would be more appropriate for evaluating response inhibition. 
An acute dose of nicotine (0.3 mg/kg) decreased mean waiting intervals and 
estimates of θ, regardless of strain or DRL schedule.  This finding is consistent with prior 
evidence of the effects of nicotine on FO-DRL performance (Kirshenbaum et al., 2011, 
2008, 2009; C. Morrison & Armitage, 1967; C. F. Morrison, 1968; Popke, Fogle, et al., 
2000; Popke, Mayorga, et al., 2000).  Acute nicotine decreases estimates of P in FO-
DRL, suggesting a nicotine-induced increase in exponentially distributed responses.  
Mazur and colleagues (2014) reported that the same does of acute nicotine had the 
opposite effect on estimates of P obtained from FMI, where trials are initiated by the rat. 
Given that nicotine can increase response rates (Bovet & Bovet, 1965; Davis, Kensler, & 
Dews, 1973; Morrison, 1967), the opportunity to rapidly produce waiting intervals in FO-
DRL (but not in FMI) may account for the paradoxical effect on P.  
Note that deficient SHR performance relative to WKY was not detected by FMI 
schedules in Chapters 1 or 2, where no strain differences were observed.  This suggests 
that some difference exists between FMI and DRL schedules that differentially affect one 
strain.  In FMI schedules, waiting intervals are initiated with a lever press and terminated 
with a head entry into the food hopper (target response).  In DRL schedules, the initial 
and terminal responses are co-located, and waiting intervals are typically produced using 
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either lever presses or head entries but not both. The separation of the initial and terminal 
response may facilitate longer waiting intervals in FMI schedules, either by the delay 
incurred from moving between operanda, or by removing the opportunity for rapid 
iterative responses.   
Another important difference between FMI and DRL schedules is that, in the FMI 
task, rats control the beginning of a waiting interval independently from the end of an 
interval; in FO-DRL, each response is both the beginning of new interval and the end of 
the previous one, except the first response after a reinforcer (see Figure 9 for visual 
depiction).  In the DT-DRL task, waiting intervals are initiated by the program.  In DRL 
schedules, rats did not control the beginning of intervals.  Thus, differences between FMI 
and DRL performance may be attributed to control over the beginning of intervals.  To 
test this possibility, waiting intervals from the final non-drug session of FO-DRL were 
examined post-hoc. The mean of the first waiting interval produced after each reinforcer 
was delivered did not differ from the overall mean waiting intervals. The absence of 
significant differences between these waiting intervals suggests that these effects cannot 
be explained simply by control over the start of the waiting interval.   
In conclusion, limiting the rate at which waiting intervals could be produced did 
not appear to improve the response-withholding performance of SHR.  SHR generated 
significantly shorter mean waiting intervals than WKY in DT-DRL and FO-DRL, 
although in SHR performance in DT-DRL was influenced by a greater proportion of 
exponentially distributed responses.  Further research is necessary to determine specific 
components of response inhibition schedules that may contribute to improved SHR 
performance, and the relation of those components to response inhibition in humans. 
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CHAPTER 5 
GENERAL DISCUSSION 
The primary purpose of Experiments 1 and 2 was first, to determine if nicotine 
improves response inhibition, and second, to determine if SHR are differentially affected 
by nicotine compared to their normotensive control strain, the WKY.  We hypothesized 
that nicotine would rescue SHR deficits in FMI performance.  Although previous 
research suggests that nicotine is detrimental to response inhibition, FMI was a novel 
approach to measuring response inhibition independent of motivational bias.  However, 
acute and chronic doses of nicotine decreased response threshold (θ) for both SHR and 
WKY rats.  Furthermore, SHR and WKY strains from both experiments (two separate 
cohorts) did not differ in their baseline response threshold. This finding was surprising, 
considering that SHR consistently perform worse than WKY on similar waiting tasks 
such as FO-DRL schedules.   
 Experiment 3 aimed at elucidating why we did not observe strain differences in 
response inhibition performance on FMI schedules.  Although FMI and FO-DRL are 
purported to measure “waiting impulsivity,” (Dalley et al., 2011) and require subjects to 
wait a specified interval between responses, subtle differences may be key to 
understanding the differential performance of WKY.  FO-DRL permits animals to 
generate waiting intervals in rapid succession, whereas FMI schedules do not.  Similarly, 
children with ADHD have been shown to perform worse in tasks where they are allowed 
to control the pace of trials, compared to tasks where the pace is controlled by the 
experimenter.  Thus, a discrete-trials version of the DRL schedule (DT-DRL) was 
employed to test the possibility that externally-paced tasks facilitate improved 
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performance.  Data from the DT-DRL task suggests that this is not the case.  Both DRL 
schedules revealed robust response inhibition deficits in SHR, in the form of reduced 
mean waiting intervals.  However, the distribution of waiting intervals suggests that 
animals were generating relatively few timed waiting intervals in DT-DRL.  To properly 
test differences between self-paced and externally paced DRL tasks, modifications may 
need to be made to the DT-DRL arrangement used in Experiment 3. 
The effects of nicotine on DRL performance agree with our findings from FMI 
schedules, and a number of previous studies (Kirshenbaum & Brown, 2008; 
Kirshenbaum et al., 2011, 2009; Mayorga, Popke, Fogle, & Paule, 2000; Popke, Fogle, et 
al., 2000).  An acute s.c. injection of  nicotine (0.3 mg/kg) significantly reduced mean 
waiting intervals and estimates of θ, regardless of strain or dose. 
Taken together, our findings do not support the hypothesis that elevated rates of 
smoking in the ADHD population are due to nicotine’s ability to ameliorate response 
inhibition deficits.  In fact, the present study and the majority of existing research suggest 
the opposite—that nicotine is detrimental to response inhibition.  Comparison data from 
FMI and DRL schedules indicate that FMI schedules may not be appropriate for studying 
response inhibition deficits in SHR.  The main advantage of FMI schedules is the ability 
to dissociate measures of response inhibition from motivational bias.  In DRL these two 
measures are confounded.  However, SHR and WKY did not display any motivational 
differences in FMI schedules, so the emergence of strain differences in DRL schedules 
cannot be explained in terms of motivational bias. Further examination of these tasks may 
highlight critical components involved in the amelioration of response inhibition deficits.  
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APPENDIX A  
THE TEMPORAL REGULATION MODEL 
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‘Waiting interval,’ refers to the time elapsed between the initial lever press and 
the terminal head entry. The Temporal Regulation model was applied to estimate 
parameters of the distribution of waiting intervals (Mika et al. 2012; Sanabria and Killeen 
2008). The model assumes that, at the beginning of every trial, rats either enter a timing 
state (with probability P) or they do not (with probability 1 – P). When in a timing state, 
rats produce waiting intervals that are gamma-distributed, centered close to the criterial 
FMI interval (here, 6 s). When rats are not in a timing state, they produce intervals at a 
constant average rate, and as such, non-timing intervals are exponentially distributed. 
Thus, according to the Temporal Regulation model, a mixture of two distributions, one 
gamma and one exponential, underlie the distribution of waiting intervals: 
  
 Pr (IRT = t | t < δ) = 0  
 Pr (IRT = t | t ≥ δ) = PΓ (t – δ; n, c) + (1 – P)(1 / K) exp (– (t – δ) / K).        (1) 
 
In Equation 1, the probability of entering a timing state, P, is the mixture weight of a 
gamma distribution with shape parameter n and scale parameter c. Both distributions, 
gamma and exponential, are shifted rightwards to account for the minimum time required 
to complete the initial and terminal response, δ. Thus, the mean duration of timed waiting 
intervals is nc + δ and the mean duration of non-timed waiting intervals is K + δ. Our 
analysis was primarily concerned with estimates of P and of the rescaled mean of the 
gamma distribution, θ = (nc + δ) / 6 s. If the mean timed waiting interval is shorter or 
longer than the 6-s criterial time, estimates of θ are, respectively, less than or greater than 
 92 
1. Estimates of θ served as indices of response inhibition performance (Sanabria and 
Killeen, 2008).  
